Other and unspecified local infections of skin and subcutaneous tissue

L12_INFECT_SKIN_NAS

Tuberculosis, Cutaneous: Tuberculosis of the skin. It includes scrofuloderma and tuberculid, but not LUPUS VULGARIS.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L08 Hospital discharge: ICD-9 — 686 Hospital discharge: ICD-8 — 68698\|6869[0-1] Hospital discharge: excluded ICD-10 — L08.1 Hospital discharge: excluded ICD-9 — 6860 Cause of death: ICD-10 — L08 Cause of death: ICD-9 — 686 Cause of death: ICD-8 — 68698\|6869[0-1] Cause of death: excluded ICD-10 — L08.1 Cause of death: excluded ICD-9 — 6860 2 out of 7 registries used, show all original rules.	4849
4. Check minimum number of events None	4849
5. Include endpoints None	4849
6. Filter based on genotype QC (FinnGen only)	4310

Control definitions (FinnGen only)

Control exclude: L12_INFECT_SKIN

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L00-L08
Name in latin: Aliae infectiones locales cutis et telae subcutaneae

NAME	L12_INFECT_SKIN_NAS
CONTROL_EXCLUDE	L12_INFECT_SKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L08
HD_ICD_9	686
HD_ICD_8	68698\|6869[0-1]
HD_ICD_10_EXCL	L08[1-2]
HD_ICD_9_EXCL	6860
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L08
COD_ICD_9	686
COD_ICD_8	68698\|6869[0-1]
COD_ICD_10_EXCL	L08[1-2]
COD_ICD_9_EXCL	6860
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other and unspecified local infections of skin and subcutaneous tissue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4310	2228	2082
Unadjusted period prevalence (%)	0.87	0.79	0.95
Median age at first event (years)	56.67	53.91	59.63

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4484: Matched controls
44840

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S97

ICPC

Chronic ulcer skin

5.9

318.4

625

1192

J01FF01

ATC

clindamycin; systemic

3.3

314.5

1780

7414

L08.0

ICD-10 Finland

Pyoderma

65.7

307.7

569

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

80.8

307.7

1942

420

A46

ICD-10 Finland

Erysipelas

4.6

307.7

1278

3560

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

8.3

307.7

458

609

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

76.6

307.7

2069

496

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

9.9

297.0

354

386

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

10.9

292.9

323

316

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.5

287.2

503

856

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.6

228.9

907

2958

J01CF05

ATC

flucloxacillin; systemic

4.4

218.2

608

1544

J01DB01

ATC

cefalexin; oral

5.0

213.9

4133

31487

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.6

198.8

292

409

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

8.8

197.6

253

301

L03.9

ICD-10 Finland

Cellulitis, unspecified

10.8

190.6

210

204

NHQ40

NOMESCO Finland

Amputation of toe

11.3

181.4

193

178

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.3

171.7

741

2520

C03CA01

ATC

furosemide; systemic

2.4

148.1

1555

8260

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.0

147.8

751

2796

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

147.6

723

2636

E0000UV, ,

ATC

2.2

145.9

2196

13516

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.8

144.9

849

3414

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.2

138.2

616

2121

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.4

131.8

1216

6055

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

131.3

2388

15607

S18

ICPC

Laceration/cut

2.1

130.4

2372

15490

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.3

129.2

269

532

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

125.9

1230

6261

J01MA12

ATC

levofloxacin; systemic

2.5

125.6

1025

4818

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

12.0

124.9

127

109

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.1

124.1

585

2075

S76

ICPC

Skin infection other

3.8

123.2

397

1106

N02AX02

ATC

tramadol; systemic, rectal

2.1

121.0

2121

13536

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

13.5

117.9

111

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.6

110.4

181

284

J01MA02

ATC

ciprofloxacin; systemic

2.0

109.2

1904

11996

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

4.4

109.1

288

692

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.5

107.3

179

286

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.3

106.0

428

1379

N02AA05

ATC

oxycodone; systemic

2.3

103.5

969

4793

L03.0

ICD-10 Finland

Cellulitis of finger and toe

3.0

102.9

511

1858

R60.0

ICD-10 Finland

Localized oedema

2.5

101.7

716

3115

A10AE04

ATC

insulin glargine; parenteral

2.8

101.4

573

2234

TQW80

NOMESCO Finland

Local dermatologic skincare

5.0

101.2

226

474

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.6

100.8

348

1013

D07AC01

ATC

betamethasone; topical

2.0

100.4

1805

11404

A10AB05

ATC

insulin aspart; parenteral

3.0

100.1

484

1733

QDA10

NOMESCO Finland

Incision of skin of lower limb

14.3

99.0

TQW11

NOMESCO Finland

Vacuum treatment of wound

6.0

98.8

178

307

H02AB06

ATC

prednisolone; systemic

1.9

98.2

2274

15607

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

96.3

616

2554

N03AX16

ATC

[U] pregabalin

2.1

96.3

1148

6237

R50.9

ICD-10 Finland

Fever, unspecified

2.3

94.2

866

4234

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

93.5

768

3576

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

93.4

940

4769

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

16.9

90.2

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

90.1

400

1361

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

4.9

89.3

200

420

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.6

88.9

587

2467

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

88.7

479

1818

68698

ICD-8 Finland

Other local infections of skin and subcutaneous tissue, Aliae definitae

+∞

87.8

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.3

87.5

181

355

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

87.3

1288

7523

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.4

87.3

695

3185

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

86.6

1014

5442

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.3

85.9

176

342

A10AC01

ATC

insulin (human); parenteral

2.9

85.1

433

1590

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

84.1

881

4523

J01DA01

ATC

[U] cefalexin

1.9

83.7

2785

21013

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

82.7

703

3309

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

6.6

82.6

135

211

127

Kela drug reimbursment

Transplant complication

6.2

82.5

142

234

ZZA00

NOMESCO Finland

Split skin graft

4.6

81.9

197

439

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

81.9

1499

9379

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

41.3

81.0

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

79.1

1422

8823

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.4

78.3

635

2924

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

5.4

78.0

158

304

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

77.9

1174

6864

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

77.7

1261

7558

L04AA06

ATC

mycophenolic acid; systemic

5.3

77.5

160

313

L17

ICPC

Foot/toe symptom/complaint

1.9

77.1

1480

9363

E000001, ,

ATC

2.0

74.8

980

5446

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

74.8

1361

8449

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.9

74.3

165

344

QBA10

NOMESCO Finland

Incision of skin of trunk

9.9

73.2

H3603, E103,

ICD-10 Finland

8.9

73.0

104

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

72.8

1478

9478

D07AB08

ATC

desonide; topical

2.4

72.4

583

2671

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.9

72.4

161

336

Z3231

NOMESCO Finland

Registered nurse

1.9

72.1

1298

8013

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

71.4

1720

11594

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.9

71.2

349

1252

S29

ICPC

Skin symptom/complaint other

2.0

70.9

1021

5852

Z94.0

ICD-10 Finland

Kidney transplant status

7.0

70.7

109

160

L30.3

ICD-10 Finland

Infective dermatitis

3.7

70.6

237

675

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

9.0

70.6

SPAT1255

SPAT

Intravenous administration of medicine

2.8

69.8

383

1460

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

69.5

376

1422

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

68.9

806

4286

J01CE08

ATC

benzathine benzylpenicillin; parenteral

7.2

68.6

102

144

P19

ICPC

Drug abuse

8.7

67.5

101

D07AD01

ATC

clobetasol; topical

2.1

67.5

816

4388

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

67.5

936

5285

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.7

67.5

126

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.2

67.3

139

272

N03AX12

ATC

[U] gabapentin; oral

2.1

67.2

783

4153

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

67.1

911

5105

NGQ20

NOMESCO Finland

Amputation of lower leg

13.0

66.6

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.3

66.3

257

803

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

10.3

66.2

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

6.3

65.9

112

182

TK800

NOMESCO Finland

Hemodialysis

4.7

65.9

155

339

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

65.1

584

2794

M79.6

ICD-10 Finland

Pain in limb

1.7

65.0

2003

14361

WX213

NOMESCO Finland

Lower leg blockade

8.0

64.7

112

ZXD05

NOMESCO Finland

Urgent procedure

1.8

64.4

1373

8869

A10AB01

ATC

insulin (human); parenteral

3.6

63.7

215

614

L73.2

ICD-10 Finland

Hidradenitis suppurativa

7.7

63.7

117

L28

ICPC

Limited function/disability (L)

2.0

63.6

897

5083

B01AB05

ATC

enoxaparin; parenteral

1.8

63.4

1392

9061

S10

ICPC

Boil/carbuncle

2.9

62.7

316

1150

ZX120

NOMESCO Finland

Intravenous

2.4

62.6

480

2146

AA1AD

NOMESCO Finland

CT of head and brain

1.8

62.5

1313

8430

P01AB01

ATC

metronidazole; oral, rectal

1.7

62.5

1739

12090

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

62.5

657

3346

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.2

62.2

132

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.9

62.0

113

197

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

61.9

1191

7446

A02BC02

ATC

pantoprazole; systemic

1.7

61.8

3019

24359

R06.0

ICD-10 Finland

Dyspnoea

1.8

61.6

1259

8014

D09AB01

ATC

zinc bandage without supplements; topical

4.7

60.9

143

312

SPAT1262

SPAT

Handing over of treatment supplies

2.0

60.6

806

4469

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.4

60.0

120

228

N02BE01

ATC

paracetamol; systemic, rectal

2.2

60.0

3982

35138

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.5

59.8

217

650

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.4

59.8

100

160

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

59.7

500

2320

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

59.7

912

5295

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.6

59.4

112

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

59.1

423

1831

R06AE07

ATC

cetirizine; oral

1.7

59.1

1957

14189

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

58.9

2376

18119

A10AE05

ATC

insulin detemir; parenteral

2.9

58.8

295

1070

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

13.6

58.8

Z2446

NOMESCO Finland

Social worker

2.6

58.8

360

1448

D07AC13

ATC

mometasone; topical

1.8

58.7

1306

8498

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.7

58.4

194

548

A28

ICPC

Limited function/disability NOS

1.9

58.3

817

4605

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

57.7

248

824

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.8

57.5

131

279

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

57.1

1950

14209

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.7

57.1

334

1312

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

57.0

736

4030

L04AD02

ATC

tacrolimus; systemic

6.3

57.0

158

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

56.9

743

4085

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.9

56.8

174

465

ZXA00

NOMESCO Finland

Right side

1.8

56.7

1139

7183

SPAT1151

SPAT

Treatment of major wounds

6.4

56.3

147

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

56.0

658

3483

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

56.0

383

1623

WX002

NOMESCO Finland

Sedation and analgesia

1.9

55.8

860

4995

A41.9

ICD-10 Finland

Sepsis, unspecified

3.4

55.7

208

634

L04AD01

ATC

ciclosporin; systemic

4.6

55.6

135

303

T89

ICPC

Diabetes insulin dependent

3.1

55.4

244

822

R4110

NOMESCO Finland

Physiotherapy

1.7

55.3

1260

8228

6869X

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Unspecified local infection of skin and subcutaneous tissue

+∞

55.3

D07AA02

ATC

hydrocortisone; topical

2.0

55.0

684

3694

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

24.6

55.0

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

54.5

478

2258

H02AB04

ATC

methylprednisolone; systemic

2.0

54.3

666

3578

A10AB04

ATC

insulin lispro; parenteral

3.6

54.2

185

532

D06AX01

ATC

fusidic acid; topical

2.3

54.2

460

2144

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

53.9

1067

6687

M86.6

ICD-10 Finland

Other chronic osteomyelitis

15.3

53.7

ZXA05

NOMESCO Finland

Left side

1.8

53.7

1050

6556

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

19.3

53.6

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

18.1

53.3

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.3

53.1

207

648

QDB10, ,

SPAT

3.8

53.1

163

436

R11

ICD-10 Finland

Nausea and vomiting

2.3

52.8

461

2173

A12AA04

ATC

calcium carbonate; oral

5.0

52.7

115

236

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

52.6

1924

14174

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

10.0

52.5

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

52.3

525

2616

SPAT1254

SPAT

Administration of medicine

2.0

52.1

699

3869

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

4.9

51.7

115

240

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

51.5

898

5409

J01DA09

ATC

[U] cefadroxil

1.7

51.5

1161

7536

N05AH04

ATC

quetiapine; oral

1.9

51.4

830

4881

137

Kela drug reimbursment

Uraemia requiring dialysis

6.7

51.3

122

SPAT1263

SPAT

Sampling

1.6

51.1

1812

13217

L04AA01

ATC

[U] ciclosporin

5.5

51.0

183

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

50.9

619

3309

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

50.6

336

1402

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.3

50.5

193

597

V03AE01

ATC

polystyrene sulfonate; oral

5.4

50.5

101

192

L30.4

ICD-10 Finland

Erythema intertrigo

5.0

50.4

109

222

S21

ICPC

Skin texture symptom/complaint

1.9

50.1

728

4134

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

50.1

1847

13583

UJF32

NOMESCO Finland

Coloscopy

1.7

49.8

1130

7337

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

12.0

49.7

A10AA01, ,

ATC

3.8

49.3

154

417

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

11.2

49.3

L04AX01

ATC

azathioprine; systemic

2.9

49.3

239

850

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.8

49.0

254

937

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.5

48.9

125

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

12.4

48.7

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

15.0

48.5

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.5

48.1

117

263

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

47.9

460

2249

A10AA02, ,

ATC

3.4

47.9

179

546

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.0

47.8

106

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

47.8

1666

12049

A06AD11

ATC

lactulose; oral

1.9

47.7

655

3647

Z3226

NOMESCO Finland

Physiotherapist

1.8

47.4

812

4850

X58

ICD-10 Finland

Exposure to other specified factors

1.9

47.4

713

4089

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.9

47.0

108

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.9

47.0

147

A11CC03

ATC

alfacalcidol; systemic

3.7

47.0

149

408

S91.3

ICD-10 Finland

Open wound of other parts of foot

3.6

46.9

157

446

R53

ICD-10 Finland

Malaise and fatigue

1.7

45.9

1149

7632

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.5

45.9

160

467

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

5.4

45.8

172

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

19.1

45.7

L03.3

ICD-10 Finland

Cellulitis of trunk

8.1

45.7

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

45.5

615

3403

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

45.4

509

2637

SPAT1301

SPAT

No procedures

1.6

45.4

1335

9237

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.2

45.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

45.2

712

4139

N05BA04

ATC

oxazepam; oral

1.7

45.1

1135

7543

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.3

44.9

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

4.6

44.8

106

233

J02AC01

ATC

fluconazole; systemic

1.6

44.6

1585

11468

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

44.4

431

2115

N02BF02

ATC

pregabalin; oral

2.3

44.3

347

1559

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

44.0

1002

6479

L20.0

ICD-10 Finland

Besnier prurigo

2.2

43.9

389

1840

S19

ICPC

Skin injury other

2.8

43.9

221

802

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.2

43.9

119

291

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

43.7

433

2140

C03DA01

ATC

spironolactone; oral

2.0

43.6

554

2999

SPAT1211

SPAT

Application of soft bandage

2.2

43.5

411

1995

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

43.3

285

1183

XQ848

NOMESCO Finland

Dermatological photography

3.2

43.2

176

566

D07BC01

ATC

betamethasone and antiseptics; topical

2.0

43.0

541

2917

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

43.0

243

937

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

42.6

1062

7027

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

42.5

1295

9008

A01

ICPC

Pain general/multiple sites

2.0

42.3

480

2495

Z72.2

ICD-10 Finland

Drug use

8.8

42.3

R52.9

ICD-10 Finland

Pain, unspecified

2.0

42.2

491

2575

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.3

42.0

327

1464

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

42.0

1477

10626

N18.8

ICD-10 Finland

Other chronic renal failure

3.7

41.9

136

378

N05BA01

ATC

diazepam; systemic, rectal

1.9

41.9

564

3111

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

16.8

41.9

B05DA

ATC

Isotonic solutions

6.6

41.6

103

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

41.6

444

2256

N06AX21

ATC

duloxetine; oral

1.9

41.5

543

2965

J01AA07

ATC

tetracycline; systemic

1.9

41.5

649

3756

M04AA01

ATC

allopurinol; systemic

1.9

41.4

574

3196

V03AE02

ATC

sevelamer; oral

8.2

41.4

N05CF01

ATC

zopiclone; oral

1.6

41.3

1328

9348

T90

ICPC

Diabetes non-insulin dependent

1.7

41.3

1031

6817

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

41.2

450

2306

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

41.1

593

3345

L73.8

ICD-10 Finland

Other specified follicular disorders

5.4

41.1

152

WX402

NOMESCO Finland

General anaesthesia

1.7

40.9

1011

6664

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

40.8

805

4990

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

7.9

40.8

QCA10

NOMESCO Finland

Incision of skin of upper limb

13.7

40.8

C07AB07

ATC

bisoprolol; oral

1.5

40.8

1995

15415

SPAT1229

SPAT

Assessment of need for aid

2.3

40.7

342

1581

E000002, ,

ATC

2.0

40.7

499

2665

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.7

40.6

131

363

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.0

40.5

180

609

N18.0

ICD-10 Finland

End-stage renal disease

5.7

40.4

133

J01MA14

ATC

moxifloxacin; systemic

2.1

40.4

418

2099

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

6.6

40.4

100

WX892

NOMESCO Finland

Monitored bed care

2.2

40.4

368

1759

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

40.1

322

1461

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

40.1

221

841

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

7.7

39.9

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.3

39.8

108

JN4AD

NOMESCO Finland

Body CT examination

1.9

39.8

520

2838

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

39.7

999

6608

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

39.7

3134

26767

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

39.6

1276

8967

R4180

NOMESCO Finland

Podiatric therapy

4.9

39.5

180

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

39.4

491

2635

B05DB

ATC

Hypertonic solutions

6.9

39.4

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.4

39.4

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.2

39.3

105

254

D07CC01

ATC

betamethasone and antibiotics; topical

1.9

39.0

556

3121

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

38.9

314

1427

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

38.7

434

2243

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.6

38.7

131

375

Z2221

NOMESCO Finland

Medical doctor

1.6

38.7

1148

7905

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

38.6

165

546

ZY010

NOMESCO Finland

Hospital outpatient

2.4

38.6

267

1134

N06AX11

ATC

mirtazapine; oral

1.6

38.3

1448

10537

J01CF02

ATC

cloxacillin; systemic

3.7

38.3

123

340

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

14.9

38.2

B03XA02

ATC

darbepoetin alfa; parenteral

3.6

38.1

127

360

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.7

38.0

194

R51.80

ICD-10 Finland

Headache

1.8

37.9

716

4376

J01XC01

ATC

fusidic acid; systemic

4.9

37.9

175

D02AE01

ATC

carbamide; topical

2.3

37.7

303

1374

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

37.6

156

507

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

37.4

239

978

J04AB02

ATC

rifampicin; systemic

4.8

37.4

177

A10BA02

ATC

metformin; oral

1.6

37.3

1168

8131

XQ802

NOMESCO Finland

Epicutan test

2.7

37.1

200

752

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

36.9

555

3166

I50.0

ICD-10 Finland

Congestive heart failure

2.2

36.9

321

1505

QXB99, ,

SPAT

3.1

36.8

158

524

N30.0

ICD-10 Finland

Acute cystitis

1.7

36.8

725

4482

N06AB04

ATC

citalopram; systemic

1.7

36.7

857

5545

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

36.6

400

2047

H3601, E103,

ICD-10 Finland

6.2

36.4

101

N03AX09

ATC

lamotrigine; oral

2.5

36.3

238

986

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

36.3

1201

8462

Z71.8

ICD-10 Finland

Other specified counselling

1.5

36.2

1480

10924

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

36.2

393

2006

M10.9

ICD-10 Finland

Gout, unspecified

2.2

36.2

330

1576

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.6

36.2

123

353

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

36.1

205

792

E000003, ,

ATC

2.6

35.9

217

864

SPAT1260

SPAT

Consultation of another employee

1.7

35.7

738

4621

J01AA02

ATC

doxycycline; systemic

1.5

35.6

3261

28363

R03AC02

ATC

salbutamol; inhalant

1.5

35.5

2330

18923

E000006, ,

ATC

2.2

35.5

300

1390

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

35.4

209

823

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

35.4

1530

11417

ZXE00

NOMESCO Finland

One hour or less

1.5

35.4

1589

11953

N02BF01

ATC

gabapentin; oral

1.9

35.3

470

2575

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.2

35.3

141

448

J01FA06

ATC

roxithromycin; oral

1.5

35.3

1614

12186

H04AA01

ATC

glucagon; nasal, parenteral

3.4

35.2

131

399

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.3

35.1

211

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

35.0

626

3761

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.7

35.0

112

309

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

34.9

572

3349

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

4.2

34.8

221

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

34.7

147

484

WZC30

NOMESCO Finland

Teaching

1.7

34.4

726

4566

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

34.3

613

3679

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

34.1

250

1089

D07XC01

ATC

betamethasone; topical

1.8

34.1

528

3036

E66.8

ICD-10 Finland

Other obesity

2.3

34.1

261

1159

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

34.1

287

1327

J01AA04

ATC

lymecycline; systemic

1.8

34.0

567

3335

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

8.4

33.8

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

33.8

394

2063

H02AB07

ATC

prednisone; oral

1.8

33.7

559

3281

WVA20

NOMESCO Finland

Medicine administration

2.9

33.6

157

547

L84

ICD-10 Finland

Corns and callosities

2.8

33.5

177

659

L12

ICPC

Hand/finger symptom/complaint

1.7

33.4

769

4947

M54.5

ICD-10 Finland

Low back pain

1.5

33.3

1546

11670

WX320

NOMESCO Finland

Spinalanesthesy

1.6

33.2

1004

6905

QWC00

NOMESCO Finland

Reoperation for superficial infection in surgery of skin

10.7

33.1

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.3

33.0

127

395

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.5

33.0

115

SPAT1153

SPAT

Removal of sutures

1.5

32.9

1264

9168

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

32.8

106

294

W19

ICD-10 Finland

Unspecified fall

1.9

32.7

442

2433

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

32.6

213

880

N05AH03

ATC

olanzapine; systemic

2.2

32.5

298

1426

N05CD07

ATC

temazepam; oral

1.9

32.4

461

2580

S20

ICPC

Corn/callosity

3.4

32.3

119

360

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

32.3

371

1932

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

32.2

130

416

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

32.2

299

1438

S06

ICPC

Rash localized

2.3

32.2

263

1201

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.6

32.0

183

709

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

32.0

365

1895

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.5

31.9

SPAT1312

SPAT

General health counselling

1.5

31.9

1309

9617

H3600, E103,

ICD-10 Finland

4.8

31.8

149

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.5

31.8

109

315

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

31.8

448

2499

205

Kela drug reimbursment

Chronic hypertension

1.6

31.7

1017

7079

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.6

31.7

169

A41.8

ICD-10 Finland

Other specified sepsis

3.6

31.6

105

297

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

10.4

31.6

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

31.4

197

799

A10AE06

ATC

insulin degludec; parenteral

2.7

31.4

174

664

Z49.2

ICD-10 Finland

Other dialysis

5.7

31.3

103

J01EA01

ATC

trimethoprim; systemic

1.6

31.0

1003

6989

N06AX16

ATC

venlafaxine; oral

1.7

31.0

604

3708

L03

ICD-10 Finland

Cellulitis

4.8

30.8

145

C08CA01

ATC

amlodipine; oral

1.5

30.8

1528

11647

A02BC05

ATC

esomeprazole; systemic

1.5

30.5

1636

12651

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

30.5

321

1618

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

30.4

313

1565

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.1

30.4

127

415

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

30.4

259

1203

N03AE01

ATC

clonazepam; systemic

2.2

30.4

257

1190

L03.2

ICD-10 Finland

Cellulitis of face

7.9

30.2

N06AB03

ATC

fluoxetine; oral

1.8

30.2

506

2974

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

30.2

756

4956

N05AX12

ATC

aripiprazole; systemic

2.5

30.1

196

809

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.4

30.0

204

859

R02

ICPC

Shortness of breath/dyspnoea

1.7

29.9

580

3556

N05BB01

ATC

hydroxyzine; systemic

2.2

29.8

275

1318

L04AX03

ATC

methotrexate; systemic

1.9

29.8

420

2340

A07AA02

ATC

nystatin; oral

2.2

29.8

251

1160

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.4

29.8

L60.0

ICD-10 Finland

Ingrowing nail

2.3

29.7

231

1033

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.7

29.7

253

X57

ICD-10 Finland

Unspecified privation

3.2

29.6

121

390

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

4.5

29.6

162

UKC02

NOMESCO Finland

Cystoscopy

1.7

29.5

656

4169

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.2

29.4

192

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.1

29.4

282

1372

RS220, ,

NOMESCO Finland

4.2

29.4

188

S06.0

ICD-10 Finland

Concussion

1.8

29.4

474

2755

G47.3

ICD-10 Finland

Sleep apnoea

1.5

29.3

975

6827

S01

ICPC

Pain/tenderness of skin

2.3

29.3

227

1013

B01AA03

ATC

warfarin; systemic

1.6

29.0

734

4821

T82

ICPC

Obesity

2.5

28.9

192

800

N05AA02

ATC

levomepromazine; systemic

2.5

28.9

181

734

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

9.5

28.8

F10.24

ICD-10 Finland

Alcohol depence active use

3.8

28.8

235

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

28.8

886

6092

SPAT1216

SPAT

Assessment of functional ability

1.7

28.8

607

3803

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.3

28.7

107

326

X84

ICD-10 Finland

Intentional self-harm by unspecified means

10.8

28.7

A08

ICPC

Swelling

2.2

28.6

259

1232

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

28.5

2428

20345

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

5.6

28.5

R5110, ,

SPAT

1.9

28.5

367

1986

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.5

28.4

190

794

NH1AD

NOMESCO Finland

Ankle and foot CT

3.1

28.4

121

400

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.0

28.3

202

NFQ20

NOMESCO Finland

Amputation of femur

5.9

28.3

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

28.3

750

4978

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

28.3

193

814

R4190

NOMESCO Finland

Nutritional therapy

2.4

28.3

205

889

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

28.2

1122

8150

6868X

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Other specified local infections of skin and subcutaneous tissue[ALIAE INFECTIONES LOCALES CUTIS ET SUBCUTIS]

+∞

28.1

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.5

28.1

173

695

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.3

27.8

166

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

27.8

323

1686

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

27.8

805

5455

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

27.8

1906

15346

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

27.7

2279

18937

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

27.6

1117

8136

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

27.6

545

3354

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

27.5

746

4977

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

27.5

249

1185

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

27.3

361

1968

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.8

27.2

226

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

27.0

299

1534

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.1

27.0

183

M25.5

ICD-10 Finland

Pain in joint

1.5

26.8

1353

10281

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.7

26.8

130

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

26.8

318

1672

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.0

26.8

121

414

A02BC01

ATC

omeprazole; systemic

1.5

26.8

1069

7759

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

9.7

26.8

WX704

NOMESCO Finland

Intubation

1.9

26.5

357

1958

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

26.4

261

1284

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

26.4

163

656

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.0

26.3

304

1583

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

8.7

26.3

N03AG01

ATC

valproic acid; systemic, rectal

2.1

26.2

259

1275

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.2

26.1

ZXA10

NOMESCO Finland

Bilateral

1.6

26.1

722

4833

OAB50, ,

SPAT

1.9

26.0

352

1934

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

25.9

297

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

25.9

317

1685

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.4

25.8

278

EBA00

NOMESCO Finland

Extraction of tooth

1.4

25.7

1528

11945

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.6

25.7

240

D02AX

ATC

Other emollients and protectives

2.6

25.6

153

607

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

25.5

1412

10895

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.9

25.4

T74.1

ICD-10 Finland

Physical abuse

3.3

25.3

286

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

9.4

25.3

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.4

25.2

267

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

25.2

284

1466

S04

ICPC

Lump/swelling localized

1.7

25.1

470

2845

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

25.1

441

2622

D05BB02

ATC

acitretin; oral

3.0

25.1

113

386

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.2

25.1

303

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

25.1

215

1001

S09

ICPC

Infected finger/toe

2.5

25.0

153

613

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.8

24.9

J05AB01

ATC

aciclovir; systemic

1.5

24.9

874

6165

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

24.9

330

1801

J04BA02

ATC

dapsone; oral

6.2

24.9

K07

ICPC

Swollen ankles/oedema

2.2

24.8

206

946

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

24.8

239

1165

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

24.8

273

1398

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.0

24.7

173

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

24.6

440

2629

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

24.6

376

2145

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.2

24.5

302

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.0

24.5

109

370

A04

ICPC

Weakness/tiredness general

1.6

24.5

674

4502

K08.3

ICD-10 Finland

Retained dental root

1.9

24.5

331

1818

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

24.5

1011

7370

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

9.4

24.4

E000007, ,

ATC

2.1

24.4

226

1085

XQ800

NOMESCO Finland

Prick test

1.9

24.3

310

1669

S11

ICPC

Skin infection post-traumatic

3.9

24.3

184

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.3

24.3

274

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

24.2

510

3186

WX214

NOMESCO Finland

Plexus blockade at the ankle

6.0

24.2

XQ855

NOMESCO Finland

Skin temperature measurement

7.3

24.2

L30.0

ICD-10 Finland

Nummular dermatitis

2.3

24.1

185

822

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

24.0

991

7218

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.6

23.9

136

526

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

23.9

316

1722

D11

ICPC

Diarrhoea

1.7

23.9

506

3167

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.5

23.8

131

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

23.8

194

885

ZXD35

NOMESCO Finland

Usual procedure

2.6

23.8

143

569

WX882

NOMESCO Finland

High dependency care

2.5

23.7

146

587

B01AB10

ATC

tinzaparin; parenteral

1.7

23.7

446

2702

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

7.4

23.7

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

23.7

252

1274

SPAT1310

SPAT

Counselling related to known health issue

1.4

23.7

1252

9554

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.2

23.6

299

A10BH05

ATC

linagliptin; oral

2.2

23.6

214

1019

K02.1

ICD-10 Finland

Caries of dentine

1.4

23.5

2465

21080

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.3

23.5

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

8.2

23.5

A29

ICPC

General symptom/complaint other

1.6

23.4

560

3614

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

23.4

190

865

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.9

23.3

176

J01CA04

ATC

amoxicillin; systemic

1.5

23.3

3493

31714

L03.8

ICD-10 Finland

Cellulitis of other sites

7.3

23.3

R33

ICD-10 Finland

Retention of urine

1.8

23.1

334

1872

M48.0

ICD-10 Finland

Spinal stenosis

1.7

23.1

469

2902

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.9

23.0

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.3

23.0

263

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.1

23.0

314

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

23.0

273

1435

N07BB01

ATC

disulfiram; oral

2.3

23.0

186

846

TPX15

NOMESCO Finland

Removal of vascular injection port

6.0

22.9

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

22.9

220

1071

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.1

22.9

152

C08CA13

ATC

lercanidipine; oral

1.6

22.9

563

3658

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

22.8

933

6773

Z00.0

ICD-10 Finland

General medical examination

1.5

22.8

788

5530

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

22.7

251

1287

A10BB12

ATC

glimepiride; oral

2.0

22.6

255

1316

R42

ICD-10 Finland

Dizziness and giddiness

1.5

22.6

906

6549

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.8

22.6

115

420

S80.0

ICD-10 Finland

Contusion of knee

1.8

22.6

326

1826

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.3

22.6

256

D11AH01

ATC

tacrolimus; topical

4.2

22.6

145

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

22.6

426

2583

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.7

22.6

194

RD210, ,

NOMESCO Finland

3.0

22.6

323

H36.01

ICD-10 Finland

Diabetic maculopathy

3.7

22.5

190

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

6.0

22.5

B01AC04

ATC

clopidogrel; oral

1.6

22.4

624

4175

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

22.3

872

6270

JN4BD

NOMESCO Finland

Extensive body CT

1.7

22.3

397

2367

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

22.3

775

5443

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.1

22.2

305

H3603, E113,

ICD-10 Finland

4.8

22.2

106

S22

ICPC

Nail symptom/complaint

1.9

22.2

289

1568

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.7

22.1

192

D01AC02

ATC

miconazole; topical

1.9

22.1

303

1670

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.0

22.1

156

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

22.1

935

6831

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

22.1

523

3365

C09AA02

ATC

enalapril; systemic

1.5

22.0

714

4938

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.0

22.0

161

NH3CG

NOMESCO Finland

Extensive MRI of foot

5.3

22.0

R03AC13

ATC

formoterol; inhalant

2.1

21.9

203

975

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

17.1

21.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

21.6

202

973

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.0

21.6

326

A10AD01

ATC

insulin (human); parenteral

3.3

21.5

249

WW200

NOMESCO Finland

Immunization

2.6

21.5

125

489

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

21.4

1628

13159

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

21.4

1135

8636

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

21.4

436

2698

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

21.3

2793

24554

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.4

21.3

221

WX290

NOMESCO Finland

Other blockage of nerve

1.4

21.3

1950

16225

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

21.2

2079

17478

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

21.1

216

1077

S71.1

ICD-10 Finland

Open wound of thigh

4.1

21.1

144

D05AX52

ATC

calcipotriol, combinations; topical

2.0

21.1

223

1126

WW500

NOMESCO Finland

Blood transfusion

2.2

21.0

173

792

N06AA09

ATC

amitriptyline; systemic

1.8

21.0

360

2123

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

21.0

160

710

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

20.9

141

592

A10BH01

ATC

sitagliptin; oral

1.7

20.9

367

2180

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

8.0

20.9

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

20.9

239

1241

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

4.3

20.8

124

RJ420, ,

NOMESCO Finland

6.6

20.8

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

20.8

190

907

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.5

20.8

210

R06AX22

ATC

ebastine; oral

1.5

20.8

661

4549

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

20.8

1065

8050

C08CA05

ATC

nifedipine; systemic

2.0

20.7

237

1230

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

20.7

3007

26801

L14

ICPC

Leg/thigh symptom/complaint

1.8

20.6

336

1954

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

20.6

118

459

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.5

20.5

207

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

20.5

359

2130

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

20.5

243

1277

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

20.4

242

R03BB04

ATC

tiotropium bromide; inhalant

1.7

20.4

384

2324

CKC12

NOMESCO Finland

Photocoagulation of retina

2.2

20.4

177

829

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

20.3

378

2281

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

20.3

533

3512

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

20.3

285

1584

R52.2

ICD-10 Finland

Other chronic pain

2.2

20.2

169

779

A03

ICPC

Fever

1.5

20.2

717

5046

L02.1

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of neck

5.5

20.2

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

20.1

285

1587

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

20.1

143

616

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

20.1

182

867

N05CF02

ATC

zolpidem; oral

1.5

20.1

662

4589

Z29

ICPC

Social problem NOS

2.7

20.1

108

407

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

20.0

171

795

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

6.0

19.9

P15

ICPC

Chronic alcohol abuse

2.4

19.9

139

593

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

19.8

936

6961

L28.1

ICD-10 Finland

Prurigo nodularis

4.6

19.8

100

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

19.8

923

6851

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.6

19.7

114

445

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

3.5

19.7

198

NH3BG

NOMESCO Finland

MRI of foot

5.0

19.7

S17

ICPC

Abrasion/scratch/blister

2.6

19.7

114

446

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.3

19.6

153

685

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.2

19.6

238

P80

ICPC

Personality disorder

5.9

19.6

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.4

19.6

109

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

19.6

398

2460

R03DC03

ATC

montelukast; oral

1.5

19.6

650

4511

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.2

19.5

3AC01, ,

NOMESCO Finland

4.0

19.5

139

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

19.5

815

5923

H01

ICPC

Ear pain/earache

1.6

19.5

483

3138

A10BJ06

ATC

semaglutide; parenteral

2.0

19.5

218

1123

R06AE09

ATC

levocetirizine; oral

1.6

19.5

567

3824

L03

ICPC

Low back symptom/complaint

1.4

19.4

1167

9049

Y96.9

ICD-10 Finland

Unspecified type of accident

2.9

19.3

325

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

19.3

775

5589

M86.1

ICD-10 Finland

Other acute osteomyelitis

15.6

19.2

L01BA01

ATC

methotrexate; systemic

2.3

19.2

149

666

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

19.2

885

6551

P99

ICPC

Psychological disorders other

2.3

19.1

139

604

P29

ICPC

Psychological sympt/compl other

1.8

19.1

316

1844

PE1AT

NOMESCO Finland

Femoral artery PTA

3.7

19.1

164

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.9

19.1

311

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

7.2

19.1

M86.8

ICD-10 Finland

Other osteomyelitis

18.2

19.1

H3600, E113,

ICD-10 Finland

3.7

19.0

160

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

18.9

202

1023

J01XX08

ATC

linezolid; systemic

4.8

18.9

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

18.9

237

1270

R4120

NOMESCO Finland

Occupational therapy

1.8

18.8

269

1502

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

5.5

18.8

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.1

18.8

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.0

18.8

276

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

18.8

226

1194

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.8

18.7

336

H05BX01

ATC

cinacalcet; oral

5.0

18.7

L73.9

ICD-10 Finland

Follicular disorder, unspecified

5.3

18.7

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

18.7

226

1196

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

18.6

289

1655

C10AC01

ATC

colestyramine; oral

2.5

18.6

115

464

M03BX02

ATC

tizanidine; oral

1.3

18.6

2465

21487

A04AA01

ATC

ondansetron; systemic, rectal

1.7

18.6

321

1896

SPAT1172

SPAT

Guidance concerning hydration

2.8

18.6

332

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

18.6

321

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

18.6

205

1051

M10.0

ICD-10 Finland

Idiopathic gout

2.2

18.5

155

715

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.2

18.5

114

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

18.5

184

908

C02AC05

ATC

moxonidine; oral

2.1

18.5

189

942

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

18.5

257

1423

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

18.4

234

1258

A02BC03

ATC

lansoprazole; oral

1.4

18.4

1051

8066

SFA10

NOMESCO Finland

One-surface restoration

1.3

18.4

2240

19280

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

18.4

293

1692

R03BA02

ATC

budesonide; inhalant

1.5

18.4

694

4940

IFC01, ,

SPAT

30.1

18.3

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

18.3

186

926

J46

ICD-10 Finland

Status asthmaticus

2.4

18.2

121

505

WX212

NOMESCO Finland

Femoral plexus blockade

2.6

18.2

103

398

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

7.5

18.2

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

6.0

18.2

B01AB04

ATC

dalteparin; parenteral

2.0

18.2

200

1024

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

18.2

217

1143

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.3

18.2

139

618

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

18.1

1581

12963

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

18.1

1040

7988

N05AX08

ATC

risperidone; systemic

1.7

18.1

325

1942

L85.3

ICD-10 Finland

Xerosis cutis

3.6

18.1

161

N05AD01

ATC

haloperidol; systemic

2.4

18.0

124

526

C07AB02

ATC

metoprolol; systemic

1.5

18.0

711

5102

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

18.0

188

945

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

4.4

18.0

100

RJ411, ,

NOMESCO Finland

5.3

17.9

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

17.9

236

1284

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

3.7

17.9

148

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.6

17.9

106

419

XQ902

NOMESCO Finland

Other photography

3.5

17.9

181

R03BA05

ATC

fluticasone; inhalant

1.5

17.9

699

5005

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

17.9

500

3339

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

17.9

1506

12282

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.9

17.8

135

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.6

17.8

158

Z00.8

ICD-10 Finland

Other general examinations

1.7

17.8

322

1928

RS221, ,

NOMESCO Finland

3.1

17.8

232

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

17.8

150

695

ZY000

NOMESCO Finland

Hospital inpatient

3.4

17.7

192

6851A

ICD-9 Finland

Pilonidal cyst, Without mention of abscess

+∞

17.7

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

17.7

379

2374

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.2

17.7

R07.3

ICD-10 Finland

Other chest pain

1.6

17.6

414

2652

R52.0

ICD-10 Finland

Acute pain

2.2

17.6

146

671

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

17.6

1574

12938

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.8

17.6

325

SPAT1240

SPAT

Therapeutic discussion

1.6

17.6

407

2598

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

17.6

242

1336

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.8

17.5

309

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

17.5

361

2238

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.3

17.5

139

628

N06AA12

ATC

doxepin; systemic

2.0

17.5

192

983

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

17.5

531

3611

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.6

17.4

104

413

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.8

17.4

142

WX872

NOMESCO Finland

Intensive care

1.9

17.4

206

1083

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.9

17.3

129

P18

ICPC

Medication abuse

4.5

17.3

R05

ICPC

Cough

1.4

17.3

979

7495

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

17.2

548

3763

J05AB11

ATC

valaciclovir; oral

1.5

17.2

555

3823

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

17.2

264

1508

E87.6

ICD-10 Finland

Hypokalaemia

2.2

17.2

143

659

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

17.2

224

1216

M05BA04

ATC

alendronic acid; oral

1.7

17.1

301

1789

R55

ICD-10 Finland

Syncope and collapse

1.6

17.0

413

2666

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.5

17.0

104

418

M86.4

ICD-10 Finland

Chronic osteomyelitis with draining sinus

31.6

17.0

SPAT1272

SPAT

Drug screening

6.6

17.0

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

17.0

393

2508

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

17.0

116

491

N03AF01

ATC

carbamazepine; oral, rectal

2.0

17.0

193

1000

V03AE03

ATC

lanthanum carbonate; oral

5.9

17.0

L30.8

ICD-10 Finland

Other specified dermatitis

2.3

17.0

124

541

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

16.9

324

1969

Z53.0

ICD-10 Finland

Procedure not carried out because of contraindication

7.2

16.9

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.4

16.9

114

480

A10AD05

ATC

insulin aspart; parenteral

3.0

16.9

250

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

5.0

16.9

N06AB10

ATC

escitalopram; oral

1.4

16.8

781

5771

A07AA09

ATC

vancomycin; oral

3.1

16.8

219

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

16.8

120

518

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

16.8

890

6731

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

4.5

16.8

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

16.8

148

698

M01AE02

ATC

naproxen; oral, rectal

1.3

16.8

2245

19478

NF3AA

NOMESCO Finland

Femur X-ray examination

2.6

16.8

374

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

16.7

328

2006

Z50.1

ICD-10 Finland

Other physical therapy

1.9

16.7

209

1118

H02AB09

ATC

hydrocortisone; systemic

2.4

16.7

113

476

A10BK01

ATC

dapagliflozin; oral

1.7

16.7

306

1838

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

16.7

135

615

6861A

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Pyogenic granuloma

+∞

16.7

C08CA02

ATC

felodipine; oral

1.7

16.6

336

2073

S91.0

ICD-10 Finland

Open wound of ankle

3.6

16.6

147

A01AB09

ATC

miconazole; local oral

1.7

16.5

306

1843

E86

ICD-10 Finland

Volume depletion

2.5

16.5

106

436

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

16.5

348

2171

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.0

16.4

187

970

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

16.4

216

1176

SPAT1125

SPAT

Stoma care and guidance

3.0

16.4

233

N06AX03

ATC

mianserin; oral

2.0

16.4

180

922

L40.8

ICD-10 Finland

Other psoriasis

4.0

16.4

112

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

16.4

338

2096

N02AC04

ATC

dextropropoxyphene; oral

2.2

16.4

133

607

B01AF02

ATC

apixaban; oral

1.5

16.4

498

3385

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.8

16.3

264

1531

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

16.3

430

2831

160

Kela drug reimbursment

exenatide

2.8

16.3

288

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.4

16.3

112

476

Z51.5

ICD-10 Finland

Palliative care

1.7

16.2

328

2022

R81

ICPC

Pneumonia

2.1

16.2

157

768

B35.3

ICD-10 Finland

Tinea pedis

1.9

16.2

196

1038

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.4

16.1

174

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

16.0

195

1034

L72.1

ICD-10 Finland

Trichilemmal cyst

1.8

16.0

265

1546

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

16.0

150

724

R31

ICD-10 Finland

Unspecified haematuria

1.6

16.0

389

2512

B07.9

ICD-10 Finland

Verruca simplex

2.1

16.0

156

765

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

5.1

16.0

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

5.1

16.0

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

15.9

192

1015

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

15.9

1067

8376

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

6.2

15.9

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.8

15.9

275

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

15.9

175

897

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

1466

5177

3.72

307.65

3.3

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

1475

4297

4.63

307.65

2.9

1.6

—

(3023368) Bacteria identified in Blood by Culture

2145

10500

3.00

278.26

7.0

4.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1280

6497

2.36

132.95

2.6

1.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2866

20269

2.15

125.78

9.4

6.6

10.65

11.91

umol/l

6.26

2770

19347

(3001604) Monocytes [#/volume] in Blood

2854

20183

2.14

124.84

10.2

6.4

0.61

0.58

e9/l

4.56

2512

17329

(3006315) Basophils [#/volume] in Blood

2855

20231

2.13

123.68

10.2

6.4

0.04

e9/l

1.84

2513

17367

(3013650) Neutrophils [#/volume] in Blood by Automated count

3087

22545

2.19

123.55

14.5

9.6

4.38

4.09

e9/l

7.73

2744

19515

(3019198) Lymphocytes [#/volume] in Blood

2897

20648

2.14

123.52

10.2

6.4

1.85

1.92

e9/l

1.87

2620

18192

(3013115) Eosinophils [#/volume] in Blood

2917

20868

2.14

122.84

10.6

6.6

0.21

0.19

e9/l

4.18

2615

18226

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1216

6239

2.30

121.55

4.3

2.6

2.27

2.33

g/l

2.40

1139

5769

(3022948) Iron [Moles/volume] in Serum or Plasma

1279

6709

2.27

121.20

4.4

2.6

11.63

13.31

umol/l

12.53

1212

6266

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2755

19361

2.10

120.67

14.1

7.4

1.21

mmol/l

4.88

2482

16784

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1013

4819

2.42

120.33

2.4

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1144

5742

2.33

120.24

4.4

2.6

20.73

23.10

5.53

1075

5347

(3013826) Glucose [Moles/volume] in Serum or Plasma

3108

22918

2.16

118.98

9.5

5.1

7.01

6.65

mmol/l

11.58

2985

21688

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2524

17327

2.04

115.93

12.8

6.7

1.20

1.21

mmol/l

3.82

2388

16082

(3024561) Albumin [Mass/volume] in Serum or Plasma

2517

17326

2.03

113.95

8.8

5.2

34.59

35.88

g/l

22.64

2399

16264

(3002032) Base excess in Venous blood by calculation

873

3998

2.47

111.95

8.8

4.1

1.73

1.78

mmol/l

0.13

797

3460

(3019069) Monocytes/Leukocytes in Blood

2639

18597

2.02

110.35

10.4

6.6

8.89

8.87

0.14

2524

17482

(3021447) Carbon dioxide [Partial pressure] in Venous blood

882

4093

2.44

109.66

8.6

4.1

5.89

5.82

kpa

1.47

862

3985

(3006504) Eosinophils/Leukocytes in Blood

2629

18540

2.01

109.23

10.3

6.6

2.84

0.04

2512

17404

(3018010) Neutrophils/Leukocytes in Blood

2644

18695

2.01

108.88

10.2

6.4

58.77

57.03

11.57

2549

17896

(3012544) pH of Venous blood

889

4155

2.42

108.71

8.7

4.1

7.37

7.38

1.08

559

2384

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

946

4552

2.37

108.28

2.4

1.8

—

(3032080) INR in Blood by Coagulation assay

2534

17683

2.00

108.00

20.2

14.8

1.27

1.25

inr

0.72

2163

14764

(3022096) Basophils/Leukocytes in Blood

2618

18535

1.99

106.34

10.5

6.6

0.67

0.68

0.38

2500

17396

(3002030) Lymphocytes/Leukocytes in Blood

2672

19068

1.99

105.87

10.4

6.5

26.04

28.01

16.90

2570

18102

(3014111) Lactate [Moles/volume] in Serum or Plasma

792

3601

2.46

102.40

11.7

8.2

1.28

1.33

mmol/l

0.71

779

3530

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

661

2790

2.61

99.87

2.0

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

799

3689

2.42

99.64

14.2

7.6

11.14

9.52

mmol/l

7.94

770

3552

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1202

6573

2.13

99.60

5.4

3.6

0.80

0.82

mmol/l

5.84

1145

6206

(3000991) Gas panel - Venous blood

773

3560

2.42

96.71

14.6

9.2

—

(3026008) Bacteria identified in Urine by Culture

1761

11271

1.93

92.25

4.3

3.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3619

29447

2.19

91.85

13.1

8.1

82.23

79.19

u/l

3.82

3499

28032

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

566

2308

2.66

91.26

2.0

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1434

8622

1.97

89.92

2.4

1.9

1.25

mg/l

0.02

1152

6615

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1654

10448

1.92

89.49

3.2

2.3

2.86

2.78

mg/l

0.80

1487

9048

(3044640) Blood type and Crossmatch panel - Blood

1902

12580

1.89

89.29

3.8

2.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1862

12272

1.88

88.03

4.1

2.6

56.90

66.62

u/l

0.82

1755

11415

(3031040) Bacteria [#/volume] in Urine by Automated count

3206

25122

1.97

87.94

7.0

4.6

1480.95

1552.96

e6/l

0.02

347

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2500

18114

1.86

87.07

4.0

2.8

—

estimate

—

(3024354) Oxygen [Partial pressure] in Venous blood

731

3436

2.35

86.58

7.3

3.6

4.79

4.58

kpa

1.73

713

3343

(3003458) Phosphate [Moles/volume] in Serum or Plasma

989

5270

2.12

86.01

13.1

6.2

1.09

1.05

mmol/l

4.22

947

4919

(3000494) Fungus identified in Specimen by Culture

909

4749

2.15

82.87

1.8

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1902

12816

1.84

82.18

5.3

3.4

85.30

90.04

e6/l

0.03

1524

9781

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1784

11802

1.85

81.66

2.8

2.2

191.84

223.61

u/l

0.94

1707

11204

(3027801) Oxygen [Partial pressure] in Arterial blood

879

4563

2.15

81.31

11.0

8.1

12.06

12.54

kpa

2.14

843

4388

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

879

4565

2.15

81.21

11.0

8.1

5.13

5.08

kpa

0.80

845

4391

(3019977) pH of Arterial blood

877

4559

2.15

80.78

11.1

8.1

7.42

0.13

461

2489

(3003396) Base excess in Arterial blood by calculation

871

4536

2.14

79.75

10.9

8.0

0.60

0.91

mmol/l

1.39

736

3713

(3018095) Leukocytes [#/volume] in Urine

2095

14654

1.81

79.06

6.2

3.9

125.69

94.55

e6/l

0.42

1576

10317

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1182

6901

1.97

78.95

4.2

2.9

1.29

1.13

e6/l

0.45

686

3649

(3037467) Urinalysis macro (dipstick) panel - Urine

3286

26376

1.92

78.45

6.8

4.4

71.87

3.09

—

(3030467) Casts [#/volume] in Urine by Automated count

1681

11055

1.83

77.35

5.1

3.3

0.43

0.40

e6/l

0.19

1310

8112

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

565

2501

2.44

75.99

10.2

4.3

24.17

24.16

mmol/l

0.03

560

2477

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1501

9591

1.85

75.38

3.8

2.4

—

(3016502) Oxygen saturation in Arterial blood

789

4053

2.15

74.37

11.5

8.5

95.45

95.74

0.60

764

3918

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

204

504

4.19

74.25

7.9

6.5

11.98

11.90

mg/l

0.09

196

474

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

473

1957

2.58

73.35

1.8

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1091

6350

1.95

72.65

4.3

3.1

3.04

2.33

e6/l

1.27

595

3081

(3018418) pH of Serum or Plasma

1714

11523

1.79

71.96

7.9

4.1

7.39

7.40

1.27

1272

8249

(36304419) Bacteria [Presence] in Urine

1602

10561

1.80

71.83

4.9

3.2

4.16

82.26

estimate

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1646

10939

1.80

71.82

2.0

1.7

19.71

20.09

nmol/l

0.48

1442

9346

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

856

4599

2.06

71.38

4.6

241.97

242.73

u/l

0.04

834

4362

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3453

28511

1.92

71.15

6.0

4.3

15.08

11.44

mm/h

27.47

3268

26767

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1663

11116

1.79

70.94

4.1

3.3

2213.52

1299.65

ng/l

4.95

1463

9545

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

363

1344

2.85

69.88

2.4

2.2

565.60

442.71

ug/l

0.32

347

1268

(3002173) Hemoglobin [Mass/volume] in Arterial blood

735

3788

2.12

68.20

12.1

8.9

118.12

122.32

g/l

5.95

721

3701

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

732

3773

2.12

67.87

3.0

2.3

0.20

0.21

g/l

3.35

679

3529

(3004119) Hemoglobin [Mass/volume] in Venous blood

539

2459

2.35

67.34

6.9

3.5

123.79

130.08

g/l

7.60

529

2384

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2297

16990

1.72

67.33

2.6

2.1

95.51

95.98

pmol/l

0.18

1291

9197

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

247

748

3.44

66.96

1.9

1.5

—

(3027945) Reticulocytes/Erythrocytes in Blood

839

4573

2.03

66.81

3.4

2.8

1.82

1.77

0.86

773

4084

(3033658) Prothrombin time (PT) actual/Normal

1512

9984

1.78

66.17

7.6

4.3

87.94

89.35

1.35

1488

9775

(3015736) pH of Urine

2242

16527

1.71

66.07

4.8

3.4

6.27

6.22

1.17

1257

9323

(3000850) Epithelial cells [#/volume] in Urine

1373

8824

1.80

65.80

4.0

2.7

5.89

5.45

e6/l

0.51

1270

8049

(3009508) Creatinine [Moles/volume] in Urine

1895

13398

1.72

64.64

5.0

3.4

7.27

7.81

mmol/l

6.05

1625

11431

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1880

13302

1.71

63.66

4.6

3.3

31.71

36.09

u/l

1.66

1779

12597

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1016

6033

1.88

62.38

3.0

2.3

29.87

29.64

0.64

987

5869

(3017143) Hepatitis C virus Ab [Presence] in Serum

845

4723

1.97

62.21

2.2

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

105

173

6.19

60.98

43.9

39.7

7.08

7.24

ug/l

0.25

157

(3021601) Nitrite [Presence] in Urine by Test strip

2622

20486

1.67

59.33

5.3

3.8

0.00

estimate

1.34

520

4290

(3023520) Reticulocytes [#/volume] in Blood

670

3507

2.07

59.02

3.2

2.8

68.66

69.01

e9/l

0.08

478

2559

(40758558) Short blood count panel - Blood

1695

11839

1.69

58.95

10.0

6.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

705

3771

2.03

58.48

2.7

2.3

363.49

376.06

nmol/l

0.88

669

3499

(3035350) Ketones [Presence] in Urine by Test strip

2637

20712

1.66

57.73

5.4

3.8

10.21

4.30

estimate

0.58

526

4358

(3009261) Glucose [Presence] in Urine by Test strip

2645

20838

1.66

56.78

5.4

3.8

0.02

0.08

estimate

0.43

492

4090

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

375

1566

2.52

56.57

2.2

1.9

1.88

2.23

ug/l

0.32

341

1398

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

304

1160

2.74

55.01

1.4

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1174

7528

1.76

54.91

5.7

3.8

264.50

582.06

ng/l

1.38

922

5775

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

409

1806

2.39

54.58

1.9

1.8

1.68

1.50

g/l

2.92

367

1564

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2301

17612

1.63

54.47

3.4

2.4

74.54

76.58

nmol/l

2.99

2121

16068

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

495

2375

2.22

54.33

13.5

10.1

24.04

24.24

mmol/l

0.75

477

2334

(3026493) Urate [Moles/volume] in Serum or Plasma

1489

10234

1.68

53.84

4.0

2.8

354.42

342.25

umol/l

4.08

1314

9104

(3026782) Osmolality of Urine

1175

7572

1.75

53.83

4.2

2.9

515.03

540.15

mosm/kgh2o

3.80

1059

6662

(40768443) Skin Pathology biopsy report

382

1651

2.44

53.43

1.4

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2437

18971

1.62

53.42

4.8

3.1

125.76

122.32

ug/l

0.31

2313

17793

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

573

2931

2.09

53.35

7.5

4.1

115.71

87.72

ng/l

5.65

523

2554

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

281

1055

2.77

52.42

2.1

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4169

37864

2.44

52.30

34.5

15.2

25.73

24.14

mg/l

2.75

3772

31005

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

474

2283

2.20

51.42

13.9

10.8

15.69

16.12

2.43

462

2200

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

506

2524

2.13

50.17

14.3

10.2

0.63

0.13

501

2506

(3021879) Hepatitis B virus core Ab [Presence] in Serum

598

3188

2.01

49.51

1.8

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

784

4593

1.86

48.90

4.0

2.9

6.77

8.02

umol/l

1.62

704

4036

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

304

1232

2.57

48.68

3.9

3.8

0.32

0.35

iu/ml

0.69

161

680

(3020682) Albumin/Creatinine [Ratio] in Urine

1722

12513

1.61

48.67

5.2

4.2

16.23

8.10

mg/mmol

4.89

1163

7915

(3019309) Folate [Moles/volume] in Red Blood Cells

989

6226

1.76

48.45

1.9

1.8

1214.33

1161.08

nmol/l

0.89

797

4763

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

202

661

3.15

48.18

4.1

3.4

283.17

1240.59

u/ml

1.11

(3011397) Hemoglobin [Presence] in Urine by Test strip

1362

9364

1.65

48.01

5.0

3.7

0.00

0.15

—

(3012516) Albumin [Mass/volume] in Urine

1694

12296

1.61

47.88

4.5

3.5

76.54

46.16

mg/l

4.89

1213

7953

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

232

835

2.88

46.79

8.8

5.8

249.56

574.05

iu/ml

0.92

114

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1924

14449

1.58

46.72

5.3

3.7

38.01

94.12

ng/l

1.04

1437

9825

(3021589) Normoblasts [#/volume] in Blood

2247

17494

1.57

46.57

18.5

11.2

0.00

e9/l

0.03

1827

14215

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1009

6456

1.73

46.39

2.2

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

519

2692

2.05

46.20

5.9

4.3

5.19

5.13

kpa

0.79

505

2588

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

675

3839

1.89

45.96

3.7

2.5

33.11

50.59

u/l

0.78

586

3253

(3027273) Bicarbonate [Moles/volume] in Venous blood

371

1704

2.28

44.97

6.4

3.4

25.20

25.19

mmol/l

0.03

363

1642

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

458

2290

2.11

44.93

5.9

4.3

1.71

1.66

mmol/l

0.08

355

1691

(3009445) Proteinase 3 Ab [Units/volume] in Serum

363

1654

2.30

44.84

1.6

1.5

24.24

15.72

iu/ml

—

(3009343) pH of Capillary blood

503

2624

2.03

43.97

6.0

4.3

7.41

7.42

1.41

440

2161

(3037522) Nuclear Ab [Titer] in Serum

882

5528

1.74

43.30

1.5

1.4

562.57

516.68

titre

0.28

187

1179

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

395

1895

2.19

43.01

6.6

3.9

50.78

47.95

1.39

390

1866

(3020630) Protein [Mass/volume] in Serum or Plasma

579

3222

1.92

41.88

3.5

2.8

65.40

66.55

g/l

2.82

535

2974

(3014051) Protein [Presence] in Urine by Test strip

1534

11154

1.57

41.50

4.0

2.8

0.07

0.05

0.12

247

(3023183) Ammonium ion [Moles/volume] in Plasma

223

848

2.72

40.50

3.0

2.9

31.24

36.17

umol/l

1.98

199

770

(3019550) Sodium [Moles/volume] in Serum or Plasma

4157

38335

2.16

39.70

37.7

17.9

139.31

139.68

mmol/l

17.02

4090

37582

(3028707) Methadone [Presence] in Urine by Screen method

196

709

2.85

39.14

6.8

2.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1753

13273

1.53

38.78

4.7

3.5

2.35

mmol/l

0.60

1599

12120

(3023103) Potassium [Moles/volume] in Serum or Plasma

4160

38430

2.14

38.62

38.2

18.1

3.99

3.97

mmol/l

5.68

4089

37601

(46235355) HIV 1 and 2 tests - Meaningful Use set

1133

7814

1.60

37.75

2.6

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

100

241

4.22

37.62

1.7

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

242

998

2.51

37.25

1.5

1.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

154

5.07

36.41

1.1

5.88

4.17

iu/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

295

1350

2.27

35.92

1.6

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

272

1204

2.34

35.80

3.9

2.9

202.74

187.32

1.95

260

1153

(3024928) Oxygen saturation in Venous blood

246

1042

2.44

35.74

7.7

3.7

64.28

61.83

0.88

238

1009

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

287

1304

2.28

35.54

3.6

2.9

92.91

92.44

0.12

274

1266

(3052851) Hemolysis interference index of Serum or Plasma

237

995

2.46

35.10

4.3

3.3

1.45

2.58

index

1.14

136

512

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

303

1419

2.22

34.88

1.4

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3382

29758

1.56

34.05

5.1

4.3

14.66

14.73

pmol/l

0.88

3124

27452

(3007930) Methemoglobin/Hemoglobin.total in Blood

326

1588

2.14

33.97

6.3

5.7

0.86

0.89

0.60

313

1497

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

344

1725

2.08

33.20

6.2

5.4

1.80

1.59

2.33

329

1628

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

175

4.58

33.11

2.2

1.4

2702244.00

1071654.90

iu/ml

—

(3036489) Thrombin time

317

1543

2.13

33.08

3.2

2.5

21.30

20.88

0.66

279

1383

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

274

1265

2.24

32.63

4.1

3.1

3.85

3.49

g/l

3.20

263

1205

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

626

3832

1.74

32.61

5.4

3.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

538

3158

1.80

32.38

3.6

2.9

10.60

g/l

0.01

502

2905

(3000475) Leukocytes [#/volume] in Synovial fluid

217

911

2.45

32.13

1.8

1.6

21790.97

12765.20

e6/l

0.98

138

630

(3022313) Gas panel - Capillary blood

364

1889

2.01

31.95

6.0

4.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1154

8265

1.53

31.64

1.7

1.5

2.49

2.39

g/l

0.94

720

5197

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

187

737

2.60

31.62

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

187

737

2.60

31.62

1.6

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

248

1114

2.30

31.52

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

1248

9119

1.51

31.03

5.5

3.9

1.02

1.35

kg/l

0.81

855

6050

(3010375) cycloSPORINE [Mass/volume] in Blood

173

4.45

30.81

29.6

29.2

111.09

117.97

ug/l

0.40

145

(3008152) Bicarbonate [Moles/volume] in Arterial blood

430

2390

1.88

30.79

8.8

6.9

24.43

mmol/l

0.01

412

2284

(3030981) Hyaline casts [#/volume] in Urine by Automated count

533

3165

1.78

30.77

3.2

2.4

0.50

0.42

e6/l

0.22

510

3024

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

511

3001

1.79

30.62

3.7

3.1

237.73

186.90

ng/l

1.64

463

2728

(3048689) Calprotectin [Mass/mass] in Stool

788

5240

1.61

29.64

2.7

2.5

163.49

131.35

ug/g

1.12

646

4227

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

201

852

2.42

29.14

1.9

1.5

—

(3045414) Leukocytes [Presence] in Urine

590

3674

1.70

28.64

2.6

2.1

0.00

0.01

estimate

1.06

113

782

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

258

1227

2.17

28.53

2.2

1.7

1.20

1.18

g/l

0.35

244

1172

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

264

1267

2.15

28.53

8.9

4.9

1.83

1.47

mg/l

5.56

245

1171

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

251

1181

2.19

28.51

2.2

1.7

0.24

0.23

g/l

0.47

234

1127

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3842

35231

1.63

28.25

6.4

5.2

1.92

1.90

mu/l

0.44

3591

32775

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

297

1499

2.05

28.10

6.5

4.8

24.82

24.70

mmol/l

0.24

284

1398

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

520

3146

1.74

28.00

2.8

2.3

6.20

7.43

ug/l

1.06

460

2789

(3017732) Neutrophils [#/volume] in Blood

740

4910

1.61

27.94

4.5

3.1

4.56

4.65

e9/l

0.13

624

4297

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

8.60

27.50

12.9

13.9

5.48

5.92

mmol/l

0.32

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

238

1118

2.19

27.14

4.3

3.5

6.71

2.93

ratio

0.66

142

640

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2862

24840

1.42

26.61

3.6

3.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

258

1263

2.11

26.47

4.4

3.7

69.17

97.29

mg/l

0.28

226

1081

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

259

1272

2.10

26.35

2.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

257

1260

2.10

26.27

4.4

3.7

37.01

64.90

mg/l

1.43

224

1081

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

199

885

2.31

25.89

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

426

2487

1.79

25.88

2.2

2.0

1.25

1.36

g/l

0.41

397

2294

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3021

26539

1.42

25.76

4.9

3.3

55.77

47.02

u/l

5.31

2877

25064

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

227

1070

2.18

25.66

1.9

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1244

9369

1.45

25.63

1.4

1.3

1.17

1.78

u/ml

1.84

308

2526

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

181

783

2.37

25.10

1.9

1.5

138.87

148.27

au/ml

0.49

226

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

211

977

2.22

24.93

1.5

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

220

1038

2.18

24.81

1.9

1.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

246

1215

2.08

24.65

5.9

2.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

266

1356

2.02

24.46

2.4

1.8

—

(3005322) IgE [Units/volume] in Serum or Plasma

442

2652

1.74

24.38

1.5

1.3

582.07

239.53

u/ml

1.53

413

2465

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

284

1484

1.98

24.35

2.6

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

121

443

2.78

23.70

1.4

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

273

1422

1.98

23.62

1.5

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

983

7193

1.47

23.15

1.4

1.3

37.59

30.29

iu/ml

0.37

270

2166

(3004809) Band form neutrophils/Leukocytes in Blood

149

615

2.47

22.93

2.9

3.6

1.17

1.40

0.40

132

551

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3888

36127

1.57

22.81

28.8

14.8

81.58

82.62

ml/min/173m2

1.86

3662

33317

(4198724) Urine methamphetamine measurement

171

3.90

22.62

3.0

1.8

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

488

3074

1.66

22.40

4.4

2.6

60.87

67.28

ml/min/173m2

2.41

210

1276

(3020191) Ethanol [Moles/volume] in Serum or Plasma

321

3.03

22.17

1.9

1.4

1.14

1.28

promille

0.37

257

(3042733) HLA Ab [Presence] in Serum

131

4.32

22.00

5.1

4.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

312

3.06

21.99

1.3

87.80

80.49

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

779

2.27

21.89

1.7

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

716

4962

1.53

21.87

2.1

1.7

1.59

1.46

5.15

620

4378

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

242

3.35

21.81

1.6

1.4

153.33

538.42

titre

—

(3028626) Oxygen [Partial pressure] in Capillary blood

226

1136

2.04

21.60

5.7

4.7

8.50

8.45

kpa

0.15

220

1111

(3047181) Lactate [Moles/volume] in Blood

231

1174

2.02

21.42

7.1

6.3

1.27

1.31

mmol/l

0.20

211

1032

(3020891) Body temperature

317

1794

1.83

21.27

6.8

4.3

36.91

36.92

°c

0.02

310

1779

(1001926) Buprenorphine [Presence] in Urine by Screen method

259

1383

1.93

20.83

5.7

1.9

—

(3037756) Immunofixation for Serum or Plasma

169

770

2.24

20.80

2.0

1.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

155

3.91

20.67

1.1

224.07

214.48

iu/ml

0.09

155

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

193

932

2.12

20.54

1.3

1.73

5.43

u/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

181

857

2.16

20.26

1.6

1.3

274.94

252.77

u/ml

0.47

126

523

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

193

937

2.11

20.25

1.7

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3809

35423

1.50

20.24

8.7

6.1

41.48

38.89

mmol/mol

36.77

3580

33324

(3025941) Bacteria identified in Stool by Culture

354

2101

1.74

20.20

1.4

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

281

1561

1.85

20.01

3.2

2.4

3.75

3.71

g/l

0.10

258

1436

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

281

1562

1.85

19.97

3.2

2.4

7.46

7.35

g/l

0.48

258

1435

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

281

1562

1.85

19.97

3.2

2.4

4.20

4.21

g/l

0.03

259

1435

(3023420) DNA double strand Ab [Units/volume] in Serum

293

1654

1.83

19.81

2.4

1.8

11.05

6.94

iu/ml

0.67

404

(40768446) Kidney Pathology biopsy report

148

3.89

19.52

2.0

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

271

3.06

19.37

2.0

1.5

24.72

21.65

u/ml

0.25

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1353

1.90

19.31

3.2

2.4

10.07

10.30

g/l

0.33

223

1214

(3000570) Elastase.pancreatic [Mass/mass] in Stool

222

1155

1.97

19.28

1.4

246.08

279.72

ug/g

1.47

130

673

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4219

40277

1.80

19.20

39.2

19.6

84.93

77.58

umol/l

14.08

4177

39813

(3000330) Specific gravity of Urine by Test strip

320

1875

1.76

19.09

4.2

3.2

1.02

ratio

0.45

297

1683

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1866

15595

1.34

19.08

5.4

3.7

0.09

0.07

estimate

0.10

420

3540

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

174

3.60

19.00

4.1

1.8

149.47

148.96

umol/l

0.00

100

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

138

601

2.34

18.91

1.4

1.2

—

(3002619) Bacteria identified in Specimen by Culture

4.75

18.67

1.4

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

262

1461

1.84

18.43

3.1

2.4

2.97

2.92

g/l

0.29

239

1335

(3037121) Protein [Mass/volume] in Urine

248

1363

1.87

18.27

5.7

3.6

419.73

407.82

mg/l

0.04

146

614

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1029

7879

1.40

18.27

1.9

1.7

4253317.07

29810724.77

pmol/l

3.19

870

6642

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

987

7523

1.40

17.96

3.3

3.0

2.46

2.45

mmol/l

3.06

866

6751

(3017181) Myelocytes/Leukocytes in Blood

529

3575

1.54

17.91

5.3

4.5

0.92

0.01

219

1050

(3017354) Segmented neutrophils/Leukocytes in Blood

102

396

2.61

17.90

3.1

3.7

61.63

56.64

1.49

343

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

201

3.32

17.87

1.2

—

(40768804) Tissue Pathology biopsy report

1830

15378

1.32

17.53

2.5

2.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

366

2.66

17.48

1.3

1.2

66.00

73.55

u/l

0.31

326

(3044889) 12 lead EKG panel

2951

26530

1.33

17.24

4.9

4.0

0.38

8409.20

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

233

1285

1.86

16.98

1.7

1.5

0.67

8.73

iu/ml

0.77

232

(3029937) Albumin [Presence] in Urine by Test strip

1396

11325

1.34

16.94

5.6

4.0

0.00

estimate

0.20

475

3944

(3020876) Protein [Mass/time] in 24 hour Urine

109

449

2.46

16.93

3.2

2.5

1.32

1.38

g/24h

0.08

268

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

110

456

2.45

16.86

1.5

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

222

1209

1.88

16.84

1.3

18.12

44.06

u/ml

0.93

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

884

6680

1.40

16.77

1.3

12.31

11.18

u/ml

0.16

285

2637

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

149

707

2.15

16.64

1.8

1.7

—

(40768797) Stomach Pathology biopsy report

732

5357

1.44

16.62

1.4

1.2

—

(3016879) Cocaine [Presence] in Urine

279

1638

1.75

16.52

6.1

1.9

—

(4024509) Urine culture

292

1737

1.73

16.51

2.3

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

119

519

2.33

16.30

1.9

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

107

447

2.43

16.14

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4178

40000

1.65

15.86

19.5

11.7

26.49

26.73

u/l

0.35

4091

38923

(3039000) Anion gap in Blood by calculation

160

795

2.05

15.84

8.2

7.7

11.61

11.32

mmol/l

0.40

148

710

(3018572) Chloride [Moles/volume] in Blood

160

796

2.05

15.79

8.2

7.7

104.45

105.15

mmol/l

0.90

148

711

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

209

1142

1.87

15.70

1.3

20.89

8.11

u/ml

0.65

175

(3024522) Salmonella sp identified in Specimen by Organism specific culture

107

453

2.40

15.69

1.5

1.4

—

(3024471) HLA-A [Type]

125

3.79

15.62

1.0

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

432

2879

1.55

15.50

1.6

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

233

2.95

15.16

3.8

1.8

—

(4195642) Thrombophilia screening test

124

569

2.21

15.09

1.3

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

395

2.46

14.99

1.4

1.3

1.30

1.46

nmol/l

0.71

356

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

206

1139

1.85

14.92

1.3

19.17

3.31

u/ml

0.42

108

(3024932) HLA-DR beta [Type]

125

3.71

14.84

1.0

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

202

1113

1.85

14.79

3.2

2.3

0.00

g/l

-0.00

179

979

(3008757) Leukocyte morphology finding [Identifier] in Blood

375

2.48

14.67

3.7

4.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

160

820

1.99

14.56

5.1

1.8

0.80

0.85

nmol/l

0.34

124

702

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

235

1364

1.76

14.49

3.3

2.4

0.62

1.01

g/l

1.18

204

1168

(3002179) Metamyelocytes/Leukocytes in Blood

490

3407

1.49

14.39

5.1

4.3

0.82

0.71

0.34

202

995

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

191

1046

1.86

14.27

1.3

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

287

1771

1.66

14.16

6.0

1.8

—

(3019225) pH of Specimen

504

3539

1.48

14.08

6.4

4.3

7.38

7.35

3.11

384

2572

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

302

1892

1.64

14.05

2.6

2.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

188

1032

1.86

13.95

3.4

2.4

0.00

g/l

-0.00

178

978

(3028300) Cannabinoids [Presence] in Urine

288

1787

1.65

13.91

6.0

1.8

—

(3027008) Opiates [Presence] in Urine

287

1781

1.65

13.86

5.9

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

176

3.15

13.82

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

191

1057

1.84

13.81

1.3

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

121

572

2.15

13.70

1.2

1.1

117.44

114.64

0.37

111

525

(3014148) Varicella zoster virus Ab [Titer] in Serum

119

560

2.16

13.63

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

112

515

2.20

13.59

1.9

1.5

—

(3021440) Promyelocytes/Leukocytes in Blood

488

3428

1.48

13.59

5.6

4.6

0.12

0.06

184

906

(36660697) Celiac disease serology panel - Serum

473

3303

1.48

13.57

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3815

36039

1.39

13.57

6.1

5.0

6.18

5.90

mmol/l

20.04

3558

33277

(3018405) Lactate [Moles/volume] in Arterial blood

217

1255

1.77

13.56

5.2

3.7

1.41

1.40

mmol/l

0.09

211

1236

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

158

827

1.94

13.56

2.8

2.3

148.35

95.79

ug/min

0.71

102

509

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

105

472

2.25

13.47

2.4

2.5

35.12

28.87

iu/ml

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

428

2.32

13.45

1.5

1.4

—

(3049717) Cytology report of Urine Cyto stain

240

1433

1.71

13.40

2.7

2.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

203

1156

1.79

13.38

3.4

2.3

0.00

0.03

g/l

1.93

190

1042

(3023199) Leukocytes [#/volume] in Pleural fluid

101

448

2.28

13.37

1.6

1.4

2495.83

4094.56

e6/l

0.37

319

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

430

2.31

13.31

1.5

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

115

541

2.16

13.20

2.0

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

115

541

2.16

13.20

2.0

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

115

541

2.16

13.20

2.0

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

115

541

2.16

13.20

2.0

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

190

1065

1.82

13.20

1.3

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

432

2.30

13.17

1.5

1.4

—

(3003181) Sodium [Moles/volume] in Urine

141

718

2.00

13.10

2.3

1.5

57.78

62.95

mmol/l

0.65

107

585

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

155

817

1.93

13.04

1.6

1.5

—

(3042517) Benzodiazepines panel - Urine

9.33

12.94

4.7

2.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

6.14

12.92

1.0

1.3

456.29

379.50

u/ml

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

169

921

1.87

12.85

3.1

2.2

127.67

130.21

g/l

0.59

131

723

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

152

800

1.93

12.85

1.7

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

124

608

2.07

12.79

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

108

504

2.17

12.66

1.6

1.5

31.91

32.79

g/l

0.32

100

455

(44816559) Phosphatidylethanol [Mass/volume] in Blood

274

1721

1.63

12.62

1.9

1.7

0.26

0.32

mg/l

0.83

115

824

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.97

12.58

1.4

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

135

3.36

12.57

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3437

32081

1.31

12.36

39.1

18.8

13.96

13.57

44.90

3409

31641

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

950

7576

1.32

12.30

1.8

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

397

2736

1.49

12.13

2.5

2.4

22.71

21.39

au/ml

0.10

310

(3024891) Influenza virus A+B Ag [Presence] in Specimen

185

1060

1.78

11.97

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

154

834

1.88

11.96

4.6

4.1

—

(3045424) Erythrocytes [Presence] in Urine

294

1904

1.58

11.94

2.6

2.2

0.01

0.44

estimate

0.50

588

(3025159) Blasts/Leukocytes in Blood

481

3452

1.44

11.93

5.9

4.7

0.12

0.21

0.43

173

845

(4268621) Lupus anticoagulant assay

438

2.22

11.92

2.5

2.3

—

(3027944) Amphetamines [Presence] in Urine

276

1764

1.60

11.85

6.2

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

427

2.23

11.80

1.6

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

126

642

1.99

11.73

1.7

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

205

2.80

11.72

1.4

1.2

47.35

24.75

u/l

0.68

169

(3009466) Valproate [Moles/volume] in Serum or Plasma

114

563

2.05

11.57

6.6

6.0

372.19

363.88

umol/l

0.26

103

506

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

266

1695

1.61

11.57

1.9

2.0

38.89

39.38

u/l

0.15

236

1525

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

214

2.73

11.38

1.4

1.1

123.96

89.08

u/l

0.68

180

(3002256) Pathology report gross observation

675

5175

1.36

11.32

1.4

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

120

610

1.99

11.26

1.5

1.2

3.90

4.41

u/ml

0.21

280

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

526

3881

1.40

11.15

4.1

4.2

19.08

22.42

ug/l

0.11

429

3144

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

367

2535

1.49

11.08

1.3

59.31

51.36

au/ml

0.27

168

(3020717) Zinc [Moles/volume] in Serum or Plasma

241

2.59

11.00

2.6

1.6

14.55

24.35

umol/l

2.88

220

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

568

4270

1.38

10.75

10.4

6.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

155

2.99

10.66

2.8

2.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

281

2.44

10.64

4.5

3.0

216.09

218.97

e6/l

0.04

235

(3045788) Cell count panel - Pleural fluid

369

2.24

10.58

1.7

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

119

618

1.95

10.53

1.5

1.2

2.38

4.14

u/ml

1.33

224

(21491868) Cryoglobulin [Mass/volume] in Serum

147

3.01

10.36

1.1

1.2

0.09

0.27

g/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

129

693

1.89

10.32

1.1

—

(3007463) Buprenorphine [Presence] in Urine

18.81

10.25

5.8

9.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

126

674

1.89

10.22

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

281

2.41

10.16

4.3

2.8

524.08

528.99

e6/l

0.02

222

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

166

2.85

10.04

2.6

3.3

1.13

0.01

166

(3003327) Ova and parasites identified in Stool by Light microscopy

225

1426

1.61

10.04

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

238

1532

1.58

9.95

1.3

1.2

0.55

1.03

u/ml

0.61

117

(1616796) Gas panel - Central venous blood

152

871

1.77

9.89

6.6

3.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

549

4158

1.37

9.89

2.0

1.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

374

2.19

9.84

2.4

2.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

108

556

1.97

9.83

1.3

1.4

22.14

24.59

u/l

0.38

465

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

447

2.08

9.82

1.2

1.1

97.48

96.58

0.11

423

(3022493) Free Hemoglobin [Mass/volume] in Plasma

174

2.78

9.79

1.9

6.6

57.44

68.44

mg/l

0.56

130

(21494755) Public health laboratory ask at order entry panel

260

3836

0.66

9.67

1.3

—

(1761868) Lipid panel - Serum or Plasma

1317

15280

0.80

9.64

3.4

3.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

209

1316

1.62

9.59

1.4

1.3

172.84

216.67

miu/ml

0.91

617

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

236

1536

1.57

9.42

2.5

2.3

7547.79

5954.01

u/l

0.27

604

(3007566) Smooth muscle Ab [Titer] in Serum

188

1161

1.65

9.33

1.2

1.3

69.29

104.51

titre

1.65

113

(3022145) Colonoscopy Study observation

573

4409

1.34

9.29

1.5

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

153

896

1.73

9.26

1.3

1.2

40.90

44.04

u/ml

0.11

(3035941) MCH [Entitic mass]

4260

41464

1.55

9.22

47.2

23.1

30.17

30.31

4.94

4213

41047

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

339

2.20

9.19

3.6

2.5

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4260

41466

1.55

9.19

47.3

23.2

91.01

90.89

0.89

4213

41050

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3710

35332

1.29

9.19

5.0

4.2

1.37

1.28

mmol/l

8.97

3464

32772

(3035320) C reactive protein [Mass/volume] in Body fluid

301

2.28

9.17

3.1

2.6

29.35

31.02

mg/l

0.12

212

(3007461) Platelets [#/volume] in Blood

4259

41457

1.54

9.15

47.5

23.3

253.78

250.34

e9/l

2.54

4198

40634

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4260

41469

1.55

9.15

48.9

23.7

39.47

40.94

10.16

4213

41034

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

173

1051

1.67

9.15

2.2

2.1

13.28

11.53

mg/l

1.34

165

981

(3000963) Hemoglobin [Mass/volume] in Blood

4261

41481

1.55

9.15

47.9

23.4

131.33

135.93

g/l

66.66

4217

41073

(3026361) Erythrocytes [#/volume] in Blood

4260

41470

1.55

9.14

47.4

23.2

4.40

4.52

e12/l

37.28

4187

40527

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

131

2.99

9.14

2.8

2.2

105.07

65.20

ug/l

1.29

126

(3012501) Base excess in Blood by calculation

140

803

1.77

9.11

7.6

4.1

2.86

2.53

mmol/l

0.81

541

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

283

2.32

9.11

1.9

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

120

657

1.85

9.10

1.1

90.31

967.15

iu/ml

0.50

142

(3010813) Leukocytes [#/volume] in Blood

4260

41474

1.54

9.09

47.5

23.3

7.07

6.72

e9/l

19.55

4183

40521

(3012441) Differential panel - Pleural fluid

382

2.11

8.97

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

3.92

8.85

2.1

2.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

479

1.98

8.85

1.7

1.6

278.58

347.19

mu/l

2.33

386

(3014271) Vancomycin [Susceptibility]

150

2.82

8.83

3.5

2.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

113

3.11

8.78

1.5

1.4

9.47

8.82

ug/l

0.42

113

(3001964) Herpes simplex virus Ag [Presence] in Specimen

108

3.16

8.76

1.7

1.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

170

1045

1.65

8.62

2.4

1.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

147

2.81

8.57

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

147

2.81

8.57

1.3

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

101

534

1.91

8.55

1.5

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

513

1.93

8.55

2.3

1.7

10346.67

924.00

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

332

2.16

8.42

1.3

215.00

170.94

titre

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

132

2.89

8.42

3.3

2.8

0.62

0.61

mmol/l

0.50

132

(3011412) CD3 cells [#/volume] in Blood

392

2.06

8.40

3.9

2.7

1219.06

1185.40

e6/l

0.11

339

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

238

2.37

8.32

3.2

2.8

35.67

42.15

1.62

132

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

387

2.06

8.31

1.6

1.8

—

(3000060) B lymphocytes [#/volume] in Blood

133

2.87

8.31

5.8

2.5

0.14

0.23

e9/l

1.11

(3028308) Erythrocytes [#/volume] in Pleural fluid

401

2.04

8.28

1.7

1.4

26263.47

88454.89

e6/l

1.90

227

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

303

2.20

8.20

4.5

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

276

1918

1.47

8.12

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

344

2.11

8.10

1.4

1.3

355.89

356.25

u/l

0.00

329

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

561

4398

1.31

7.95

2.7

2.1

—

(3004616) Nuclear Ab [Presence] in Serum

502

1.89

7.76

1.4

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

116

662

1.77

7.74

1.9

1.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

179

2.53

7.73

1.2

1.1

3.86

24.00

u/ml

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3919

37758

1.30

7.70

6.5

5.6

2.54

2.71

mmol/l

27.59

3683

35392

(3004775) Volume in Urine collected for unspecified duration

267

2.23

7.62

2.7

2.1

730.00

628.03

1.03

177

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

223

2.35

7.60

1.6

1.5

13.45

6.07

u/l

0.85

184

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

605

4822

1.29

7.58

2.7

2.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

125

734

1.72

7.56

3.3

3.4

0.84

0.81

nmol/l

0.30

592

(3003694) ABO and Rh group [Type] in Blood

1331

11589

1.21

7.56

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

336

2456

1.40

7.51

3.3

3.6

4.39

4.52

pmol/l

1.51

309

2201

(3041096) Erythrocytes [Presence] in Urine by Automated

1294

11253

1.21

7.41

4.6

3.2

0.65

0.11

estimate

0.43

418

3374

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

226

2.32

7.39

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

196

1295

1.54

7.38

1.8

1.4

9.35

9.06

u/l

0.10

156

1028

(4035726) Immunohistochemistry procedure

436

3336

1.34

7.31

1.6

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

221

2.32

7.30

1.1

1.08

1.06

ratio

0.40

179

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

228

2.30

7.25

1.3

—

(3022621) pH of Urine by Test strip

402

3049

1.35

7.15

3.2

2.5

6.03

6.09

0.64

278

2042

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

187

2.42

7.08

1.5

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

187

2.42

7.08

1.5

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

187

2.42

7.08

1.5

1.9

—

(3024263) Appearance of Synovial fluid

181

2.45

7.07

1.3

1.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.76

7.07

1.9

2.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

377

1.98

7.05

1.5

1.4

6.55

6.30

mmol/l

0.26

352

(3010144) Erythrocytes [#/volume] in Synovial fluid

336

2.04

7.05

1.4

185326.63

90880.96

e6/l

0.38

233

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

166

1070

1.57

6.99

2.1

1.4

489.92

557.32

mg/l

0.74

159

1014

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

556

4434

1.29

6.91

5.1

4.8

32.32

32.21

0.08

397

2975

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

6.69

6.80

13.3

14.1

170.55

177.67

e6/l

0.03

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

301

2.07

6.75

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

124

751

1.67

6.74

1.6

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

198

2.34

6.71

2.0

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

198

2.34

6.71

2.0

1.5

—

(3016750) Collection duration of Urine

205

2.31

6.66

2.7

2.0

511.83

491.23

min

0.79

152

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

371

2811

1.35

6.65

2.7

2.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.01

6.61

1.2

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

187

2.37

6.61

1.5

1.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

312

2.03

6.52

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

275

1993

1.40

6.49

1.6

1.4

27.62

25.68

iu/l

0.37

222

1680

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

318

2362

1.37

6.48

2.6

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

396

1.91

6.47

1.9

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

313

2.03

6.47

1.2

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

293

2.06

6.45

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

273

2.10

6.45

2.2

1.3

39.93

34.32

mmol/l

0.67

246

(40759836) Histone Ab [Presence] in Serum by Immunoblot

314

2.02

6.41

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

206

1419

1.47

6.40

3.4

3.7

1383.61

3638.66

u/ml

0.53

181

1231

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.06

6.35

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

379

1.91

6.28

1.6

—

(3028433) Virus identified in Specimen by Culture

114

2.73

6.26

1.4

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3860

37290

1.25

6.23

5.9

4.9

4.40

4.61

mmol/l

32.93

3654

35094

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.67

6.19

1.9

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

394

3048

1.32

6.14

7.6

3.7

1.22

1.23

mmol/l

0.07

353

2641

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

166

1106

1.52

6.08

1.2

1.1

4.34

4.28

0.03

153

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

307

2.00

6.07

1.9

1.5

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

398

1.87

6.07

1.7

1.6

62.69

59.86

0.23

241

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.16

6.01

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

364

1.91

6.00

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

222

2.17

5.96

1.8

1.4

1.22

1.29

nmol/l

0.15

164

(3021387) Prolactin [Units/volume] in Serum or Plasma

218

1542

1.43

5.92

1.7

345.68

286.81

mu/l

0.79

191

1406

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

324

1.96

5.91

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

304

1.99

5.87

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

505

1.76

5.86

1.2

1.3

344.38

334.80

pmol/l

0.06

428

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

146

954

1.55

5.86

2.1

1.4

4.04

3.70

mmol/l

1.65

136

896

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3835

37072

1.24

5.83

5.7

4.9

1.38

1.44

mmol/l

19.72

3605

34683

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

211

2.19

5.83

1.2

1.1

1595.78

1535.89

miu/ml

0.14

211

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

11.13

5.79

8.4

9.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

114

706

1.63

5.74

1.7

1.6

0.67

0.79

g/l

0.70

565

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.19

5.58

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

250

3363

0.73

5.56

1.7

3.46

3.48

mmol/l

0.07

167

2281

(3037692) Legionella sp identified in Specimen by Organism specific culture

122

2.55

5.53

1.6

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

140

2.44

5.52

1.3

0.30

0.29

g/l

0.16

114

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

203

2.18

5.52

4.7

1.9

25.98

28.45

umol/l

0.67

189

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

355

4533

0.76

5.50

1.9

3.58

3.52

ratio

0.37

273

3456

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

159

2.34

5.48

2.8

2.4

136.06

158.32

nmol/l

0.72

141

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

111

2.62

5.47

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

109

677

1.63

5.44

1.9

3.87

4.95

mmol/24h

3.39

607

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

135

2.46

5.44

1.5

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

135

2.46

5.44

1.5

2.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

179

1241

1.46

5.43

1.4

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

141

931

1.53

5.42

2.6

1.5

28.78

29.51

e6/l

0.02

109

692

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

392

1.82

5.40

3.7

3.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

328

1.90

5.39

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

328

1.90

5.39

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

328

1.90

5.39

1.5

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

155

2.33

5.32

1.0

1.1

89.34

92.84

0.30

122

(3051611) Lipemic interference index of Serum or Plasma

351

1.86

5.31

5.5

3.3

12.89

13.26

index

0.11

212

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1762

16084

1.16

5.24

2.2

1.9

1.46

1.36

mmol/l

3.99

1523

13677

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

142

948

1.51

5.21

2.6

1.6

3425.87

1150.38

e6/l

0.34

115

748

(3023419) Bacteria identified in Sputum by Culture

516

1.70

5.20

3.1

2.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

313

1.90

5.10

3.5

1.8

5.34

4.14

mg/l

0.71

304

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.73

5.09

30.5

6.6

6.63

5.33

kpa

1.11

(3036525) Urea [Moles/time] in 24 hour Urine

8.35

5.05

4.4

4.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

446

1.74

5.02

8.5

4.5

8.72

7.14

mmol/l

2.13

372

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.43

4.90

3.8

3.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

136

2.36

4.89

1.5

2.1

—

(4015189) Microbial culture of sputum

2.78

4.87

3.7

2.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

384

1.78

4.85

1.3

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

444

1.72

4.82

2.2

2.1

29.13

20.63

mg/l

0.79

158

(3035933) Granulocytes/Leukocytes in Blood

131

875

1.51

4.82

3.7

3.2

57.08

58.06

0.35

131

875

(3023487) Leukocytes [#/volume] in Peritoneal fluid

137

2.35

4.82

2.4

2.2

23176.92

670.32

e6/l

0.52

101

(37208534) Antinuclear antibody arbitrary concentration in serum

125

2.41

4.79

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

11.45

4.78

2.6

11.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

257

1.96

4.77

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

491

1.68

4.76

3.4

2.8

—

(3000285) Sodium [Moles/volume] in Blood

2.89

4.75

1.3

1.2

138.60

139.18

mmol/l

0.27

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.41

4.74

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

307

1.87

4.74

1.2

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3375

32411

1.17

4.68

41.3

19.5

330.98

332.78

g/l

23.31

3360

32223

(3044007) Cell count panel - Peritoneal fluid

121

2.41

4.63

1.8

2.0

—

(3038026) Centromere Ab [Units/volume] in Serum

304

1.85

4.56

1.2

—

45.09

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.72

4.50

1.2

2.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

242

1831

1.34

4.46

4.2

3.3

46.60

64.21

u/ml

0.76

232

1765

(3043410) Blood group antigens tested for on Red Blood Cells

105

2.48

4.45

1.7

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

307

1.83

4.43

2.0

1.5

—

(3008295) Osmolality of Serum or Plasma

471

1.67

4.42

1.3

1.5

277.39

279.20

mosm/kgh2o

0.29

354

(3047189) Immunofixation for 24 hour Urine

182

2.10

4.41

1.3

1.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.69

4.41

1.5

1.2

101.50

77.60

—

(3044927) Protein electrophoresis panel - Urine

366

1.76

4.41

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1457

0.64

4.37

1.0

1.1

0.71

0.64

ratio

0.41

178

(3000093) Morphology [Interpretation] in Blood Narrative

390

1.73

4.35

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

245

1.93

4.34

1.3

1.5

4.93

6.96

u/l

1.80

217

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

267

1.88

4.30

1.9

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

253

1.91

4.29

1.3

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

103

1544

0.66

4.25

1.1

1.2

1.53

1.52

g/l

0.16

103

1544

(3011985) Renin [Units/volume] in Plasma

547

1.60

4.22

1.4

65.03

86.70

mu/l

0.35

490

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

248

1.90

4.19

1.7

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.81

4.18

2.8

4.7

2.04

5.51

—

(3017569) Oxygen content in Arterial blood

214

1.97

4.15

2.5

2.3

14.93

16.34

1.77

214

(3044242) Glucose [Moles/volume] in Arterial blood

214

1.97

4.15

2.6

2.1

8.19

8.33

mmol/l

0.08

214

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.89

4.12

5.2

3.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

128

2.27

4.12

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

129

2.26

4.05

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

267

1.84

3.98

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

130

2.24

3.98

1.4

17.64

15.42

pmol/l

0.18

112

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

246

1.88

3.96

1.9

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

104

695

1.51

3.89

1.6

1.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.57

3.88

1.3

1.2

89.86

70.67

—

(3006653) Thiamine [Moles/volume] in Blood

220

1.92

3.86

1.3

154.83

132.05

nmol/l

1.91

220

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

126

2.23

3.82

1.3

1.1

79.43

87.81

0.60

(3044009) aPTT.lupus sensitive (LA screen)

3.95

3.79

1.3

1.2

—

(21494434) Karyotype in Bone marrow

361

1.70

3.78

1.3

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

324

1.74

3.76

1.2

109.59

108.04

pmol/l

0.09

324

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

127

2.21

3.76

1.3

84.07

86.38

0.09

(3028679) Herpes simplex virus Ab [Presence] in Serum

231

1.87

3.68

1.1

1.2

—

(3004451) EKG impression Narrative

210

1.91

3.67

1.3

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

122

2.22

3.66

2.2

2.1

9645.08

18834.38

e6/l

0.25

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

225

1.87

3.63

1.1

—

(3033099) Centromere Ab [Titer] in Serum

2.48

3.62

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

346

1.69

3.51

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

153

1123

1.38

3.50

2.2

1.9

177.87

209.99

pmol/l

3.84

148

1067

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.16

3.50

6.1

6.2

392.38

453.77

umol/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

135

972

1.40

3.47

1.1

3.90

2.55

u/ml

0.50

522

(3025577) Chromium [Mass/volume] in Blood

209

1.87

3.39

2.0

2.2

3.68

2.24

ug/l

0.49

177

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

327

1.69

3.39

1.3

1.83

2.11

mmol/l

2.05

307

(3003329) Lymphocytes/Leukocytes in Synovial fluid

314

1.70

3.31

1.8

1.5

29.74

31.29

0.12

189

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.92

3.29

2.2

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

325

2665

1.24

3.26

1.2

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

116

2.16

3.21

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

213

1.84

3.21

1.4

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

149

1983

0.74

3.19

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.54

3.19

1.1

—

(44806071) Cardiolipin IgM antibody measurement

2.86

3.19

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

419

1.58

3.17

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

103

719

1.44

3.17

1.2

1.3

32.58

39.79

u/l

0.32

621

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

117

2.14

3.15

4.4

2.7

5.04

4.87

kpa

0.32

117

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

117

2.14

3.15

4.4

2.7

10.27

10.16

kpa

0.03

117

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.26

3.13

1.1

1.2

0.20

0.02

u/ml

0.76

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

237

1.78

3.12

2.0

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

116

832

1.40

3.08

1.1

0.93

0.90

u/ml

0.02

375

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

470

1.54

3.08

1.2

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

119

859

1.40

3.05

1.1

6.17

4.72

u/ml

0.43

478

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

322

1.65

3.04

1.4

1.3

1.71

2.55

u/ml

0.45

182

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.26

3.02

2.0

1.4

0.79

0.26

mmol/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

112

802

1.41

3.01

1.1

1.34

1.67

u/ml

0.31

414

(3019174) dRVVT (LA screen)

3.34

3.01

1.3

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

529

1.50

3.01

2.2

2.4

6.11

7.28

umol/l

0.38

386

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.30

3.00

1.4

1.2

27.60

26.11

g/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

139

1037

1.35

2.93

1.1

7.25

5.43

eliau/ml

0.13

137

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

101

2.18

2.92

1.5

1.1

16.82

9.35

pmol/l

—

(40762887) Creatinine [Moles/volume] in Blood

4.10

2.88

1.3

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

424

1.54

2.82

1.5

1.3

0.43

0.38

g/l

0.27

317

(3027135) IgG subclass 1 [Mass/volume] in Serum

425

1.54

2.79

1.5

1.3

6.66

6.49

g/l

0.13

317

(3028192) IgG subclass 2 [Mass/volume] in Serum

425

1.54

2.79

1.5

1.3

2.58

2.92

g/l

0.77

318

(3041672) Baker's yeast Ab [Presence] in Serum

3.58

2.78

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.58

2.78

1.0

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.58

2.78

1.4

4.35

4.32

mg/l

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

458

1.51

2.77

1.4

1.3

—

nmol/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.27

2.76

2.2

2.0

16.05

18.28

umol/l

0.36

(3023410) Appearance of Cerebral spinal fluid

426

1.53

2.76

3.9

1.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

556

1.47

2.76

1.1

1.51

1.50

g/l

0.07

509

(4062490) Immunoglobulin typing, IgG

418

1.54

2.76

1.5

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

132

1.98

2.69

1.2

1.5

66.62

137.74

nmol/24h

0.83

132

(3017704) Immunofixation for Urine

204

1.77

2.68

2.3

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.22

2.67

4.4

5.1

—

(3000012) Reticulocyte production index

585

1.44

2.67

2.5

2.1

0.85

0.89

0.24

386

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

280

1.65

2.66

1.2

1.1

—

1.53

—

(3045142) Bone marrow Pathology biopsy report

463

1.50

2.65

1.5

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

140

1.93

2.64

1.1

12.39

13.64

u/ml

0.09

(3026692) Albumin [Mass/volume] in Peritoneal fluid

106

2.08

2.62

2.0

1.4

11.00

13.01

g/l

0.60

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

331

2787

1.20

2.61

1.2

75.66

134.32

u/ml

4.25

123

1024

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

482

1.48

2.58

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

474

1.48

2.58

1.4

1.3

0.17

0.22

nmol/l

0.72

380

(3034092) Cytoplasmic Ig cells/cells in Blood

2.86

2.54

13.8

8.7

0.25

0.19

0.33

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

796

0.65

2.52

2.0

1.8

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.23

2.51

6.3

4.0

—

(40768793) Breast Pathology biopsy report

113

839

1.36

2.50

1.4

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.27

2.50

1.5

3.1

1.29

1.98

mmol/l

—

(40758292) HTLV I+II Ab panel - Serum

2.27

2.50

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

224

1.70

2.50

2.6

2.0

172.66

114.83

ng/l

0.58

224

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

129

1.94

2.49

1.4

147.00

128.15

nmol/l

0.18

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.47

2.48

1.0

1.1

—

41.43

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

553

1.44

2.47

1.4

1.3

0.33

0.28

nmol/l

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

2.20

2.47

1.6

1.2

18.00

23.62

0.38

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

195

1.75

2.46

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

382

1.53

2.45

1.1

—

(3034426) Prothrombin time (PT)

130

1.93

2.45

1.3

1.2

27.48

29.09

0.64

130

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

656

1.40

2.42

1.4

1.5

0.31

0.39

nmol/l

0.76

505

(3008898) HLA-B27 [Presence]

176

1397

1.27

2.42

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

375

1.53

2.42

1.7

2.7

19.53

19.91

nmol/l

0.10

355

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1405

13125

1.10

2.39

5.3

5.4

2.12

3.14

ug/l

2.16

1265

11914

(3036180) Methadone [Presence] in Urine

6.26

2.37

10.6

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

2.21

2.37

1.1

1.3

211.71

50.15

mu/l

1.00

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

190

1.74

2.37

2.8

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

492

1.45

2.36

1.4

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

2.38

2.29

2.3

1.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.48

2.27

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

109

820

1.34

2.25

3.5

3.6

524.22

771.54

u/ml

0.25

100

751

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

147

1857

0.78

2.23

1.5

1.6

930.75

1017.45

mu/l

0.58

121

1552

(3002079) Sodium [Moles/time] in 24 hour Urine

179

1.74

2.22

1.2

1.4

158.82

169.81

mmol/24h

0.20

179

(3035880) pH of Pleural fluid

202

1.69

2.20

1.4

1.3

7.39

7.40

0.18

145

(3006922) Hepatitis E virus Ab [Presence] in Serum

328

1.53

2.18

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

320

1.54

2.18

1.1

233.23

275.74

mg/l

1.10

274

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

151

1.79

2.15

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

2.30

2.14

1.1

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

204

1.67

2.13

8.9

6.4

32.44

15553.15

u/ml

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

123

1.87

2.11

1.1

1.2

7.24

2.38

u/ml

0.31

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

331

1.52

2.11

1.2

1.1

35.60

40.68

mg/l

0.72

270

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.20

2.09

73.9

4.8

103.88

98.92

g/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

433

3805

1.15

2.08

3.1

2.3

12.36

13.34

nmol/l

1.82

391

3447

(3036670) Protein [Mass/volume] in Synovial fluid

103

1.95

2.05

1.4

1.3

35.69

38.91

g/l

0.34

(3025130) Human papilloma virus identified in Specimen

567

1.38

2.03

1.8

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

730

1.34

2.03

1.1

3.40

15.44

au/ml

5.96

185

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.40

2.02

6.6

3.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.23

2.00

10.2

7.4

10.89

10.54

0.17

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

209

1.63

1.97

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

298

1.52

1.92

1.3

1.1

341.53

376.83

nmol/l

0.47

265

(40768441) Liver Pathology biopsy report

282

1.53

1.92

2.0

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

472

1.40

1.91

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

318

1.48

1.83

1.2

1.4

10.79

8.86

mmol/l

1.51

304

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.27

1.80

1.7

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.96

1.79

1.1

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

207

1.60

1.79

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

263

1.53

1.78

1.0

1.1

0.36

1.29

u/ml

1.31

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

119

942

1.27

1.76

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

178

1474

1.22

1.76

1.5

1.6

21.21

16.00

u/ml

0.42

348

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.98

1.74

1.3

1.20

1.17

mmol/l

0.57

(3040893) Potassium [Moles/volume] in Capillary blood

3.85

1.71

3.4

2.5

4.50

4.46

mmol/l

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.85

1.71

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

274

1.50

1.71

1.0

1.2

0.64

2.70

u/ml

1.39

(3023430) Cat dander IgE Ab [Units/volume] in Serum

638

1.32

1.70

1.0

1.1

8.31

4.40

u/ml

0.95

288

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

141

1.71

1.68

1.5

1.7

40.85

40.48

g/l

0.11

141

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.80

1.65

1.9

1.6

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.57

1.61

3.6

7.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

894

0.75

1.61

1.5

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.38

1.61

2.5

2.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.50

1.59

1.3

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

206

1.56

1.59

1.3

1.4

47.60

68.38

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.95

1.59

2.5

1.8

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.69

1.58

8.9

4.6

—

(40768795) Lymph node Pathology biopsy report

380

1.40

1.56

1.3

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

440

1.37

1.55

1.1

—

4.38

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

256

1.49

1.55

1.7

1.5

78.61

84.07

umol/l

0.45

256

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.89

1.54

1.1

—

(4146454) Self-monitoring of blood glucose

382

1.39

1.52

2.8

2.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.60

1.51

2.3

2.4

0.57

0.59

ug/l

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.60

1.51

1.1

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

123

1.71

1.50

1.8

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

249

2165

1.16

1.46

1.1

—

(3017509) Phencyclidine [Presence] in Urine

2.37

1.45

5.0

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.73

1.43

1.5

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.04

1.43

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

156

1.61

1.43

1.2

1.1

11.55

5.98

u/ml

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

692

1.28

1.43

1.1

8.16

3.85

u/ml

1.06

352

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.85

1.40

1.1

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

502

4584

1.11

1.36

1.6

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

240

1.46

1.34

1.0

1.1

0.35

4.16

u/ml

0.83

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

175

1.55

1.34

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.15

1.33

1.1

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.36

1.29

1.4

3.4

—

(40768800) Prostate Pathology biopsy report

861

0.77

1.28

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

276

1.42

1.28

2.0

1.9

1.57

1.51

u/field

0.04

145

(4034850) Laboratory test

138

1157

1.20

1.28

14.0

9.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

606

1.28

1.27

1.1

0.78

0.24

u/ml

0.47

203

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.00

1.27

2.6

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

701

0.75

1.26

1.6

1.5

52.67

59.65

ug/l

0.82

701

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.04

1.22

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

125

1.60

1.17

2.0

1.3

16.94

16.47

umol/l

0.13

106

(1002224) Polysomnography panel

222

1952

1.14

1.16

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

248

1.41

1.16

1.3

1.2

0.60

0.57

ratio

0.17

137

(3000034) Microalbumin [Mass/volume] in Urine

326

1.35

1.13

2.8

3.0

156.66

48.90

mg/l

1.04

245

(4281824) Cell count and differential, peritoneal fluid

378

1.33

1.13

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

309

1.36

1.13

1.1

—

(40757373) Influenza virus identified in Isolate

1.75

1.12

2.1

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

175

1.49

1.12

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

130

1102

1.19

1.10

1.9

2.1

3.19

9.02

iu/l

0.61

465

(3045683) HLA typing for celiac disease panel - Blood or Tissue

234

1.41

1.10

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.26

1.10

2.9

2.3

1.14

0.65

u/field

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.38

1.09

4.8

4.7

—

(40761536) Microorganisms panel - Urine sediment

344

3123

1.11

1.08

6.3

3.9

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.87

1.07

4.2

2.0

1.25

1.30

umol/l

0.21

(3036071) Salmonella sp Ab [Titer] in Serum

129

1.55

1.05

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.96

1.03

2.9

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

146

1.51

1.03

1.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

843

0.80

1.02

1.6

—

(3005033) Fetal Nuchal fold Thickness US

809

0.80

1.01

1.5

1.19

1.26

0.59

570

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

591

1.24

1.00

1.1

1.45

3.16

—

107

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1047

0.83

0.99

1.5

55.84

58.90

ug/l

0.29

870

(3039443) Prostate specific Ag panel - Serum or Plasma

773

0.80

0.98

1.7

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

1.81

0.98

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

164

1433

1.15

0.98

2.0

1.9

—

32.21

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.74

0.96

1.6

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.89

0.94

1.1

1.80

1.85

umol/24h

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.22

0.93

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.65

0.88

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

289

1.32

0.87

1.4

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

130

0.54

0.87

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.61

0.87

3.9

2.7

250.64

357.21

ug/l

0.10

(40765096) Chromosome analysis panel by Banding

128

1.49

0.85

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.94

0.84

1.3

1.8

53.00

44.35

umol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

821

0.83

1.5

—

(40762365) Oxygen content in Arterial blood by calculation

1.76

0.83

2.9

2.6

14.37

14.97

ml/dl

—

(3001729) Color of Synovial fluid

1.82

0.79

1.3

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

497

0.78

0.79

1.2

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.56

0.78

2.7

3.3

122.33

150.05

ng/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.77

0.76

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

105

1209

0.87

0.76

1.4

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.54

0.75

1.1

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.08

0.74

18.6

6.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

113

1291

0.87

0.74

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.64

0.73

1.1

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

254

1.30

0.73

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.53

0.68

1.0

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.60

0.68

2.1

2.0

32.55

32.82

pmol/l

0.01

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

968

0.87

0.64

1.4

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.72

0.64

1.6

1.5

437.60

312.14

umol/24h

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

977

0.87

0.63

1.4

1.5

1.19

1.12

ratio

0.28

590

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

316

1.24

0.60

1.0

1.1

3.93

9.29

iu/ml

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

307

1.24

0.60

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

757

7883

0.95

0.60

3.3

3.2

0.73

0.77

ug/l

0.79

518

5098

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.13

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

979

0.88

0.57

1.4

1.5

1.09

1.18

ratio

0.45

596

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

979

0.88

0.57

1.4

1.5

0.96

0.94

ratio

0.09

592

(3014891) Appearance of Pleural fluid

1.48

0.57

1.5

1.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

159

1.32

0.55

1.8

2.2

25.33

29.92

0.70

159

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

186

1.29

0.54

1.9

1.5

1.00

3.66

u/field

1.42

137

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.54

0.53

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.41

0.51

1.7

2.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

153

1.31

0.50

1.4

1.2

920.00

1006.06

titre

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.49

1.1

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.52

0.48

1.0

7.91

6.71

u/ml

—

(4094501) Cardiovascular stress test using bicycle ergometer

1065

0.90

0.46

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

319

1.19

0.45

1.4

158.94

195.44

pmol/l

0.49

319

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.45

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

210

1.24

0.45

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.37

0.44

1.0

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

130

1.31

0.43

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

184

1.25

0.43

5.6

4.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

317

0.82

0.42

1.1

10.18

17.21

u/ml

—

127

(3011897) Casein IgE Ab [Units/volume] in Serum

1.38

0.42

1.0

1.5

0.00

1.58

u/ml

2.02

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

4.84

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.41

0.0

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

606

1.12

0.40

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

1.43

0.39

2.2

1.5

24.00

15.57

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.43

0.39

1.2

1.0

96.00

90.51

titre

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

106

1.32

0.39

1.4

1.3

54.89

55.04

0.00

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.39

0.38

3.4

1.8

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.33

0.37

1.4

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.35

0.37

1.2

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

143

1.26

0.36

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

180

1.22

0.35

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

1.30

0.33

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

491

1.12

0.33

1.3

7.45

7.11

mmol/l

0.33

436

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.30

0.33

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.30

0.30

1.4

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.30

0.30

1.0

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1074

10537

1.03

0.29

4.7

4.4

22.58

21.84

0.79

515

5113

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

563

1.10

0.29

1.1

2.76

2.80

eliau/ml

0.01

256

(3051387) C reactive protein [Mass/volume] in Capillary blood

794

1.08

0.29

4.4

3.2

31.66

27.35

mg/l

0.47

536

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

238

0.84

0.28

1.2

1.1

1.06

1.13

u/l

—

111

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

122

1.23

0.27

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

104

1.25

0.26

1.2

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.25

0.24

1.2

1.3

4.73

489.93

ug/l

—

(4211845) Urine protein measurement

180

0.83

0.24

3.9

3.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.32

0.23

1.6

1.3

5.66

5.97

mmol/l

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.32

0.23

1.0

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

579

5662

1.03

0.22

1.7

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.25

0.22

1.0

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.22

0.22

1.8

1.1

14.08

16.83

g/l

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

209

0.86

0.21

1.1

1.2

8.56

9.37

mm/h

0.13

209

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.16

0.21

1.0

1.1

0.01

0.29

u/ml

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.20

0.19

2.2

1.6

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.18

0.19

1.2

1.0

—

(3006462) Nitrate [Presence] in Urine

165

0.85

0.19

4.1

3.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

118

1.19

0.19

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.13

0.18

4.8

7.4

16.07

8.41

mmol/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

119

1.18

0.17

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

119

1.18

0.17

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

119

1.18

0.17

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

119

1.18

0.17

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

119

1.18

0.17

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

149

1432

1.04

0.17

1.8

4.34

4.05

mg/l

0.20

121

1049

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

237

0.89

0.17

1.3

1.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.21

0.17

1.1

1.2

0.01

7.73

u/ml

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

372

0.91

0.17

4.7

5.4

129.26

66.19

u/ml

0.27

114

(3048879) Bone marrow aspiration report

101

1.19

0.16

1.7

2.1

—

2.00

—

(3041806) Other cells [#/volume] in Blood by Manual count

140

1.14

0.15

1.3

1.5

0.52

0.50

e9/l

0.20

140

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.18

0.14

1.4

22.20

31.97

—

(3002523) Influenza virus A Ag [Presence] in Specimen

753

1.05

0.14

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

353

1.08

0.14

1.5

1.4

—

(4133840) Spirometry

0.83

0.13

1.5

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

190

0.89

0.13

2.1

2.0

1.83

2.67

u/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

641

0.95

0.12

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

115

1.13

0.10

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

752

1.04

0.10

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.0

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.05

0.08

1.3

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

107

1.12

0.08

2.6

3.2

37.83

44.85

0.41

107

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

107

1.12

0.08

5.2

6.4

6.58

7.89

0.55

107

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.03

0.08

1.3

1.1

—

(44813793) Dust mix specific IgE antibody measurement

267

0.94

0.08

1.2

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.81

0.08

1.0

2.14

3.20

kpa

—

(3006598) pH of Arterial cord blood

0.79

0.08

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.79

0.08

1.0

8.20

7.45

kpa

—

(3020491) Glucose [Moles/volume] in Blood

274

1.06

0.07

2.6

1.5

9.71

6.68

mmol/l

1.73

189

(44806420) Estimation of glomerular filtration rate

422

1.04

0.07

2.5

2.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.06

0.07

1.7

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

157

1.08

0.07

2.0

3.0

1.97

1.13

ug/l

0.63

148

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.11

0.06

1.0

26.35

35.81

iu/ml

0.29

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

269

0.97

0.02

1.0

36.42

42.61

ng/l

0.56

182

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

269

0.97

0.02

1.0

269.40

312.90

ng/l

0.78

186

(3020650) Glucose [Presence] in Urine

142

1.06

0.02

1.3

1.8

0.07

0.02

estimate

0.28

142

(3029396) Erythrocyte agglutination [Presence] in Blood

1.08

0.02

2.9

3.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

163

1.04

0.01

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

267

0.97

0.01

1.0

823.74

730.78

ng/l

0.72

179

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

109

1.01

0.00

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

116

1161

1.00

0.00

1.5

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.26

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.00

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.95

-0.00

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.96

-0.00

1.1

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.94

-0.00

1.3

66.50

64.81

ug/l

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.96

-0.00

1.1

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.87

-0.00

1.0

6.53

8.33

mu/l

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.96

-0.00

1.1

1.2

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: L12_INFECT_SKIN_NAS – Other and unspecified local infections of skin and subcutaneous tissue

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other and unspecified local infections of skin and subcutaneous tissue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other and unspecified local infections of skin and subcutaneous tissue (L12_INFECT_SKIN_NAS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints